<!DOCTYPE html SYSTEM "about:legacy-compat"><html lang="en" class="win-std-desktop-val"><head>
<META http-equiv="Content-Type" content="text/html">
<title>Source View: https://classic.clinicaltrials.gov/ct2/show/NCT04065399?term=NCT04065399&amp;draw=2&amp;rank=1</title><meta name="robots" content="noindex,nofollow"><meta name="SortSite-IgnoreRule-Page" content="AccHtmlLinkTextReused,AccAdvancedReadingLevel,Section508-m-3,BugHtmlColgroup,BugIeCssMinMaxWidthHeight,ErrSpellingError,SeoBingTitleLength,SeoPage150k,UseGov5.1,UseGov9.2.3,UseGov10.11,UseGov11.7,UseGov14.3,UseGov17.4,UseGunningFog,W3cTitleTooLong"><link rel="icon" href="https://www-powermapper-com.azureedge.net/favicon.ico"><link rel="stylesheet" href="../Report/report-min-20200618.css"><script type="text/javascript" src="../Report/report-min-20210409.js"></script><!--[if lte IE 8]>
            <script>
                document.createElement('header');
                document.createElement('aside');
            </script>
            <![endif]--></head><body class="source"><a class="accessible" href="#content">Skip to Content</a><header><h1>
                        HTML Document
                    </h1><table><tr><th>
                        URL:
                    </th><td><a rel="nofollow" target="_top" href="https://classic.clinicaltrials.gov/ct2/show/NCT04065399?term=NCT04065399&amp;draw=2&amp;rank=1">https://classic.clinicaltrials.gov/ct2/show/NCT04065399?term=NCT04065399&amp;draw=2&amp;rank=1</a></td></tr><tr><th>
                        HTTP Status:
                    </th><td>200 OK</td></tr><tr><th>
                        MIME Type:
                    </th><td>text/html </td></tr><tr><th>
                        Last Modified:
                    </th><td>Mon, 01 Jan 1601 00:00:00 GMT</td></tr><tr><th>
                        Download Time:
                    </th><td>1 seconds
                            </td></tr><tr><th>
                        Cookies:
                    </th><td> Psid=vihzm6CL8w0BLDFBcyz3FQ7V  CTOpts=Qihzm6CL8w0BLDFBcyUgzw </td></tr><tr><th>
                        Size:
                    </th><td>122 KB
                        </td></tr><tr><th>
                                Depth:
                            </th><td>4 clicks from home page
                            </td></tr><tr><th>
                                Charset:
                            </th><td>utf-8</td></tr><tr><th>
                                Forms:
                            </th><td>1 forms containing 3 controls
                            </td></tr><tr><th>
                        HTTP Headers:
                    </th><td><button class="chevron toggleChevron" data-toggleid="HttpHeaders"><img width="20" height="20" alt="View Headers" id="chevHttpHeaders" src="../Report/chevron-down.svg"></button>&nbsp;<span>9&nbsp;headers</span><div class="links" id="expand-HttpHeaders">Connection: close<br>Date: Wed, 27 Sep 2023 21:56:38 GMT<br>Server: Apache<br>Set-Cookie: CTOpts=Qihzm6CL8w0BLDFBcyUgzw-R98F5OR4P-doB; Expires=Wed, 27-Sep-2023 22:16:38 GMT; Path=/; Secure; HttpOnly<br>Strict-Transport-Security: max-age=31536000; includeSubDomains; preload<br>Transfer-Encoding: chunked<br>X-Frame-Options: SAMEORIGIN<br>X-UA-Compatible: IE=Edge<br>X-XSS-Protection: 1; mode=block<br></div></td></tr><tr><th>
                        Links In:
                    </th><td><button class="chevron toggleChevron" data-toggleid="LinksIn"><img width="20" height="20" alt="View Links" id="chevLinksIn" src="../Report/chevron-down.svg"></button>&nbsp;<span>1&nbsp;pages</span><div class="links" id="expand-LinksIn"><a class="viewsource" rel="nofollow" target="_top" href="https://content.montefioreeinstein.org/cancer/research/blood-institute/bci-research/translational-clinical-trials" data-pageid="6639" data-line="0" data-col="0">https://content.montefioreeinstein.org/cancer/research/blood-institute/bci-research/translational-clinical-trials</a><br></div></td></tr><tr><td>&nbsp;</td><td>&nbsp;</td></tr><tr class="middle"><th><img alt="OK" width="20" height="20" src="../Report/bench-better.svg">
                                Issues:
                            </th><td>
                                No issues found
                            </td></tr></table></header><main id="content" class="pre"><p><code>1</code><code>          </code></p><p><code>2</code><code>          </code></p><p><code>3</code><code>          </code></p><p><code>4</code><code>          </code></p><p><code>5</code><code>          </code></p><p><code>6</code><code>          </code></p><p><code>7</code><code>          </code></p><p><code>8</code><code>          </code></p><p><code>9</code><code>          </code></p><p><code>10</code><code>          </code></p><p><code>11</code><code>          </code></p><p><code>12</code><code>          </code></p><p><code>13</code><code>          </code></p><p><code>14</code><code>          </code></p><p><code>15</code><code>          </code></p><p><code>16</code><code>          </code></p><p><code>17</code><code>          </code></p><p><code>18</code><code>          </code></p><p><code>19</code><code>          </code></p><p><code>20</code><code>  </code></p><p><code>21</code><code>          </code></p><p><code>22</code><code>          </code></p><p><code>23</code><code>          </code></p><p><code>24</code><code>          </code></p><p><code>25</code><code>          </code></p><p><code>26</code><code>          </code></p><p><code>27</code><code>          </code></p><p><code>28</code><code>          </code></p><p><code>29</code><code>          </code></p><p><code>30</code><code>          </code></p><p><code>31</code><code>          </code></p><p><code>32</code><code>          </code></p><p><code>33</code><code>          </code></p><p><code>34</code><code>          </code></p><p><code>35</code><code>          </code></p><p><code>36</code><code>          </code></p><p><code>37</code><code>          </code></p><p><code>38</code><code>          </code></p><p><code>39</code><code>          </code></p><p><code>40</code><code>          </code></p><p><code>41</code><code>          </code></p><p><code>42</code><code>          </code></p><p><code>43</code><code>          </code></p><p><code>44</code><code>          </code></p><p><code>45</code><code>          </code></p><p><code>46</code><code>          </code></p><p><code>47</code><code>          </code></p><p><code>48</code><code>          </code></p><p><code>49</code><code>          </code></p><p><code>50</code><code>          </code></p><p><code>51</code><code>          </code></p><p><code>52</code><code>          </code></p><p><code>53</code><code>          </code></p><p><code>54</code><code>          </code></p><p><code>55</code><code>          </code></p><p><code>56</code><code>          </code></p><p><code>57</code><code>          </code></p><p><code>58</code><code>          </code></p><p><code>59</code><code>          </code></p><p><code>60</code><code>          </code></p><p><code>61</code><code>          </code></p><p><code>62</code><code>          </code></p><p><code>63</code><code>          </code></p><p><code>64</code><code>          </code></p><p><code>65</code><code>          </code></p><p><code>66</code><code>          </code></p><p><code>67</code><code>          </code></p><p><code>68</code><code>          </code></p><p><code>69</code><code>          </code></p><p><code>70</code><code>          </code></p><p><code>71</code><code>          </code></p><p><code>72</code><code>          </code></p><p><code>73</code><code>          </code></p><p><code>74</code><code>&lt;!DOCTYPE html&gt;</code></p><p><code>75</code><code>&lt;html xmlns="https://www.w3.org/1999/xhtml" lang='en'&gt;</code></p><p><code>76</code><code>&lt;head&gt;  </code></p><p><code>77</code><code>  &lt;meta http-equiv="X-UA-Compatible" content="IE=edge" /&gt;</code></p><p><code>78</code><code>  &lt;meta name="viewport" content="width=device-width, initial-scale=1"&gt;</code></p><p><code>79</code><code>  &lt;meta http-equiv="content-type" content="text/html; charset=UTF-8" /&gt;</code></p><p><code>80</code><code>    &lt;meta name="robots" content="noindex,nofollow"/&gt;</code></p><p><code>81</code><code>    &lt;meta name="referrer" content="origin-when-cross-origin"/&gt;</code></p><p><code>82</code><code>  &lt;title&gt;A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation - Full Text View - ClinicalTrials.gov&lt;/title&gt;</code></p><p><code>83</code><code>    &lt;link href="/ct2/show/NCT04065399" rel="canonical"/&gt;</code></p><p><code>84</code><code>    </code></p><p><code>85</code><code>  &lt;!-- Twitter Card data --&gt;</code></p><p><code>86</code><code>  &lt;meta name="twitter:card" content="summary"&gt;</code></p><p><code>87</code><code>  &lt;meta name="twitter:image" content="https://clinicaltrials.gov/ct2/html/images/ct.gov-nlm-nih-square-logo.png?v1"&gt;</code></p><p><code>88</code><code>          </code></p><p><code>89</code><code>  &lt;!-- Open Graph data --&gt;</code></p><p><code>90</code><code>  &lt;meta property="og:type" content="article" /&gt;</code></p><p><code>91</code><code>  &lt;meta property="og:title" content="A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation - Full Text View - ClinicalTrials.gov"&gt;</code></p><p><code>92</code><code>  &lt;meta property="og:image" content="https://clinicaltrials.gov/ct2/html/images/ct.gov-nlm-nih-square-logo.png?v1"&gt;</code></p><p><code>93</code><code>    &lt;meta property="og:description" content="A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation - Full Text View."&gt;</code></p><p><code>94</code><code>  &lt;meta property="og:url" content="https://clinicaltrials.gov/ct2/show/NCT04065399"&gt;</code></p><p><code>95</code><code>    </code></p><p><code>96</code><code>  &lt;link rel="shortcut icon" href="/ct2/html/images/favicon.ico" /&gt;</code></p><p><code>97</code><code>  &lt;link rel='apple-touch-icon-precomposed' href='/ct2/html/images/apple-touch-icon-144x144.png' sizes='144x144'&gt;</code></p><p><code>98</code><code>  &lt;link rel='apple-touch-icon-precomposed' href='/ct2/html/images/apple-touch-icon-114x114.png' sizes='114x114'&gt;</code></p><p><code>99</code><code>  &lt;link rel='apple-touch-icon-precomposed' href='/ct2/html/images/apple-touch-icon-72x72.png'   sizes='72x72'&gt;</code></p><p><code>100</code><code>  &lt;link rel='apple-touch-icon-precomposed' href='/ct2/html/images/apple-touch-icon-precomposed.png' &gt;</code></p><p><code>101</code><code>  &lt;link rel='apple-touch-icon-precomposed' href='/ct2/html/images/apple-touch-icon.png' &gt;</code></p><p><code>102</code><code>          </code></p><p><code>103</code><code>  &lt;link rel="stylesheet" type="text/css" href="/ct2/html/jquery/css/superfish.css?v=48" media="screen" /&gt;</code></p><p><code>104</code><code>  &lt;link rel="stylesheet" type="text/css" href="/ct2/html/jquery/css/superfish-vertical.css?v=48" media="screen" /&gt;</code></p><p><code>105</code><code>  &lt;link rel="stylesheet" type="text/css" href="/ct2/html/css/glossary.css?v=48" /&gt;</code></p><p><code>106</code><code>  &lt;link rel="stylesheet" type="text/css" href="/ct2/html/css/base.css?v=48" /&gt;</code></p><p><code>107</code><code>  &lt;link rel="stylesheet" type="text/css" href="/ct2/html/css/print.css?v=48" media="print" /&gt;</code></p><p><code>108</code><code>  &lt;link rel="stylesheet" href="/ct2/html/css/w3-ct.css?v=48" type="text/css" /&gt;</code></p><p><code>109</code><code>  &lt;!--[if lt IE 9]&gt;</code></p><p><code>110</code><code>	&lt;link rel="stylesheet" href="/ct2/html/css/w3-ct-oldIE.css?v=48" type="text/css" /&gt;</code></p><p><code>111</code><code>  &lt;![endif]--&gt;</code></p><p><code>112</code><code>   	</code></p><p><code>113</code><code>  &lt;link rel="preconnect" href="https://use.fontawesome.com"&gt;</code></p><p><code>114</code><code>  &lt;link rel="preconnect" href="https://www.ncbi.nlm.nih.gov"&gt;</code></p><p><code>115</code><code>  </code></p><p><code>116</code><code>  &lt;script src="https://use.fontawesome.com/20a31629ec.js"&gt;&lt;/script&gt;</code></p><p><code>117</code><code>&lt;!--[if lte IE 7]&gt;</code></p><p><code>118</code><code>       &lt;link href="/ct2/html/css/target-IE7-and-below.css" rel="stylesheet" type="text/css"&gt;</code></p><p><code>119</code><code>&lt;![endif]--&gt;</code></p><p><code>120</code><code>          </code></p><p><code>121</code><code>&lt;style type="text/css"&gt;</code></p><p><code>122</code><code>  h2 </code></p><p><code>123</code><code>  {</code></p><p><code>124</code><code>      background-color: #EAEAEA;</code></p><p><code>125</code><code>  }</code></p><p><code>126</code><code>&lt;/style&gt;</code></p><p><code>127</code><code>&lt;link href="/ct2/html/css/trial-record.css?v=48" rel="stylesheet" type="text/css" /&gt;</code></p><p><code>128</code><code>          </code></p><p><code>129</code><code>	&lt;script type="text/javascript" src="/ct2/html/jquery/js/jquery.min.js?v=48"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>130</code><code>&lt;script type="text/javascript" async src="/ct2/html/jquery/js/superclick.min.js?v=48"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>131</code><code>&lt;script type="text/javascript" async src="/ct2/html/js/ct.js?v=48"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>132</code><code>&lt;script type="text/javascript" async src="/ct2/html/js/ctmenu.js?v=48"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>133</code><code>&lt;script&gt;</code></p><p><code>134</code><code>var theURL = "/ct2/show/NCT04065399?term=NCT04065399&amp;draw=2&amp;rank=1"+window.location.hash;</code></p><p><code>135</code><code>history.replaceState(null,null,theURL);</code></p><p><code>136</code><code>&lt;/script&gt;</code></p><p><code>137</code><code>          </code></p><p><code>138</code><code>  &lt;meta name="ncbi_sid" content="4ec6157c5146f356_130e19SID"/&gt;</code></p><p><code>139</code><code>  &lt;meta name="ncbi_app" content="ctgov"/&gt;</code></p><p><code>140</code><code>  &lt;meta name="ncbi_db" content="ctgov"/&gt;</code></p><p><code>141</code><code>  &lt;meta name="ncbi_pdid" content="show_study"/&gt;</code></p><p><code>142</code><code>  &lt;meta name="ncbi_pcid" content="NCT04065399"/&gt;</code></p><p><code>143</code><code>  &lt;meta name="ncbi_ctreqid" content="R9805PDV"/&gt;</code></p><p><code>144</code><code>  &lt;meta name="ncbi_ctsessid" content="S9804wlv"/&gt;</code></p><p><code>145</code><code>  &lt;meta name="ncbi_ctipid" content="IjatRiK3"/&gt;</code></p><p><code>146</code><code>  &lt;meta name="ncbi_cthost" content="w13"/&gt;</code></p><p><code>147</code><code>  &lt;meta name="ncbi_ctterm" content="NCT04065399"/&gt;</code></p><p><code>148</code><code>  &lt;meta name="ncbi_ctrank" content="1"/&gt;</code></p><p><code>149</code><code>&lt;/head&gt;</code></p><p><code>150</code><code>          </code></p><p><code>151</code><code>          </code></p><p><code>152</code><code>&lt;body&gt; </code></p><p><code>153</code><code>&lt;script type="text/javascript"&gt;</code></p><p><code>154</code><code>    jQuery.getScript("https://www.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {</code></p><p><code>155</code><code>      galert(['#alert_banner', 'body &amp;gt; *:nth-child(1)'])});</code></p><p><code>156</code><code>&lt;/script&gt;</code></p><p><code>157</code><code>          </code></p><p><code>158</code><code>&lt;div id="alert_banner"&gt;&lt;/div&gt;</code></p><p><code>159</code><code>          </code></p><p><code>160</code><code>          </code></p><p><code>161</code><code>          </code></p><p><code>162</code><code>&lt;!-- eff6fb / aa0000; f9dede/black; ac2020/white --&gt;</code></p><p><code>163</code><code>&lt;!--</code></p><p><code>164</code><code>&lt;div style="display:flex; flex-direction:row; justify-content:center; background-color:#f9dede; margin-top:0px; padding: 10px 0 10px 0;"&gt;</code></p><p><code>165</code><code>    &lt;div style="text-align:center; color:black; font-size:18px; font-weight:700;"&gt;</code></p><p><code>166</code><code>        Maintenance test banner&lt;/br&gt;</code></p><p><code>167</code><code>        Line # 2</code></p><p><code>168</code><code>    &lt;/div&gt;</code></p><p><code>169</code><code>&lt;/div&gt;</code></p><p><code>170</code><code>--&gt;</code></p><p><code>171</code><code>          </code></p><p><code>172</code><code>&lt;div style="width:100%; height:8px; background-color:#ffbe2e;"&gt;&lt;/div&gt;</code></p><p><code>173</code><code>&lt;div id="longAlert" style="width:100%; background-color:#faf3d1; padding: 10px 0px; "&gt;</code></p><p><code>174</code><code>    &lt;div style="max-width: 1200px; margin: 0px auto; display:flex; align-items: center; font-size:14px; font-weight:700; padding:0px 8px;"&gt;</code></p><p><code>175</code><code>        &lt;div style="margin-right:1rem; display:flex; justify-content: center;"&gt;&lt;img src="/ct2/html/images/icon-disclaimer.png" width="24" height="24"/&gt;&lt;/div&gt;</code></p><p><code>176</code><code>        </code></p><p><code>177</code><code>                        &lt;div&gt;</code></p><p><code>178</code><code>            This is the classic website, which will be retired eventually. Please visit the modernized &lt;a href="https://www.clinicaltrials.gov" title="Follow link"&gt;ClinicalTrials.gov&lt;/a&gt; instead.</code></p><p><code>179</code><code>                    &lt;/div&gt;</code></p><p><code>180</code><code>    &lt;/div&gt;</code></p><p><code>181</code><code>&lt;/div&gt;</code></p><p><code>182</code><code>&lt;div style="width:100%; height:8px; background-color:#ffbe2e; margin-bottom:-8px;"&gt;&lt;/div&gt;</code></p><p><code>183</code><code>&lt;!--</code></p><p><code>184</code><code>&lt;div id="shortAlrt" style="display:block;margin-left:auto;margin-right:auto;border-bottom: 1px solid #aeb0b5;"&gt;</code></p><p><code>185</code><code>&amp;nbsp;</code></p><p><code>186</code><code>&lt;/div&gt;</code></p><p><code>187</code><code>--&gt;</code></p><p><code>188</code><code>          </code></p><p><code>189</code><code>          </code></p><p><code>190</code><code>          </code></p><p><code>191</code><code>          </code></p><p><code>192</code><code>&lt;!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--&gt;</code></p><p><code>193</code><code>&lt;script type='text/javascript'&gt;</code></p><p><code>194</code><code>/*</code></p><p><code>195</code><code>(function(){var g=function(e,h,f,g){</code></p><p><code>196</code><code>this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b&lt;e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null};</code></p><p><code>197</code><code>this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "};</code></p><p><code>198</code><code>this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&amp;&amp;(e=Math.random()&gt;=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0};</code></p><p><code>199</code><code>this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g+ "&amp;t=" + (new Date()).getTime();document.body&amp;&amp;document.body.appendChild(a)}};</code></p><p><code>200</code><code>this.start=function(){var a=this;window.addEventListener?window.addEventListener("load",function(){a.go()},!1):window.attachEvent&amp;&amp;window.attachEvent("onload",function(){a.go()})}};</code></p><p><code>201</code><code>try{(new g(100,"r","QSI_S_ZN_7WHWRcRMBs9xWYd","https://zn7whwrcrmbs9xwyd-nlmenterprise.siteintercept.qualtrics.com/WRSiteInterceptEngine/?Q_ZID=ZN_7WHWRcRMBs9xWYd")).start()}catch(i){}})();</code></p><p><code>202</code><code>*/</code></p><p><code>203</code><code>/*</code></p><p><code>204</code><code>$(window).on('error', function(e){</code></p><p><code>205</code><code>	// this will prevent error propagation from qualtrics</code></p><p><code>206</code><code>	// window.addEventListener('error', (e) =&gt; { e.preventDefault(); });</code></p><p><code>207</code><code>	// window.onerror = function(message, source, lineno, colno, error){ event.preventDefault(); });</code></p><p><code>208</code><code>	console.log('eondow.error', event.message)</code></p><p><code>209</code><code>	e.preventDefault();		// stop reporting (and maybe execution) of failed script</code></p><p><code>210</code><code>})</code></p><p><code>211</code><code>*/</code></p><p><code>212</code><code>(function () {</code></p><p><code>213</code><code>    var g = function (e, h, f, g) {</code></p><p><code>214</code><code>        this.get = function (a) {</code></p><p><code>215</code><code>            for (var a = a + "=", c = document.cookie.split(";"), b = 0, e = c.length; b &lt; e; b++) {</code></p><p><code>216</code><code>                for (var d = c[b]; " " == d.charAt(0); ) d = d.substring(1, d.length);</code></p><p><code>217</code><code>                if (0 == d.indexOf(a)) return d.substring(a.length, d.length);</code></p><p><code>218</code><code>            }</code></p><p><code>219</code><code>            return null;</code></p><p><code>220</code><code>        };</code></p><p><code>221</code><code>        this.set = function (a, c) {</code></p><p><code>222</code><code>            var b = "",</code></p><p><code>223</code><code>                b = new Date();</code></p><p><code>224</code><code>            b.setTime(b.getTime() + 6048e5);</code></p><p><code>225</code><code>            b = "; expires=" + b.toGMTString();</code></p><p><code>226</code><code>            document.cookie = a + "=" + c + b + "; path=/; ";</code></p><p><code>227</code><code>        };</code></p><p><code>228</code><code>        this.check = function () {</code></p><p><code>229</code><code>            var a = this.get(f);</code></p><p><code>230</code><code>            if (a) a = a.split(":");</code></p><p><code>231</code><code>            else if (100 != e) "v" == h &amp;&amp; (e = Math.random() &gt;= e / 100 ? 0 : 100), (a = [h, e, 0]), this.set(f, a.join(":"));</code></p><p><code>232</code><code>            else return !0;</code></p><p><code>233</code><code>            var c = a[1];</code></p><p><code>234</code><code>            if (100 == c) return !0;</code></p><p><code>235</code><code>            switch (a[0]) {</code></p><p><code>236</code><code>                case "v":</code></p><p><code>237</code><code>                    return !1;</code></p><p><code>238</code><code>                case "r":</code></p><p><code>239</code><code>                    return (c = a[2] % Math.floor(100 / c)), a[2]++, this.set(f, a.join(":")), !c;</code></p><p><code>240</code><code>            }</code></p><p><code>241</code><code>            return !0;</code></p><p><code>242</code><code>        };</code></p><p><code>243</code><code>        this.go = function () {</code></p><p><code>244</code><code>			try {</code></p><p><code>245</code><code>				if (this.check()) {</code></p><p><code>246</code><code>					var a = document.createElement("script");</code></p><p><code>247</code><code>					a.type = "text/javascript";</code></p><p><code>248</code><code>					a.src = g + "&amp;t=" + new Date().getTime();</code></p><p><code>249</code><code>					document.body &amp;&amp; document.body.appendChild(a);</code></p><p><code>250</code><code>				}</code></p><p><code>251</code><code>			}</code></p><p><code>252</code><code>			catch(ex) {}</code></p><p><code>253</code><code>        };</code></p><p><code>254</code><code>        this.start = function () {</code></p><p><code>255</code><code>            var a = this;</code></p><p><code>256</code><code>            window.addEventListener</code></p><p><code>257</code><code>                ? window.addEventListener(</code></p><p><code>258</code><code>                      "load",</code></p><p><code>259</code><code>                      function () {</code></p><p><code>260</code><code>                          a.go();</code></p><p><code>261</code><code>                      },</code></p><p><code>262</code><code>                      !1</code></p><p><code>263</code><code>                  )</code></p><p><code>264</code><code>                : window.attachEvent &amp;&amp;</code></p><p><code>265</code><code>                  window.attachEvent("onload", function () {</code></p><p><code>266</code><code>                      a.go();</code></p><p><code>267</code><code>                  });</code></p><p><code>268</code><code>        };</code></p><p><code>269</code><code>    };</code></p><p><code>270</code><code>    try {</code></p><p><code>271</code><code>        new g(100, "r", "QSI_S_ZN_7WHWRcRMBs9xWYd", "https://zn7whwrcrmbs9xwyd-nlmenterprise.siteintercept.qualtrics.com/WRSiteInterceptEngine/?Q_ZID=ZN_7WHWRcRMBs9xWYd").start();</code></p><p><code>272</code><code>    } catch (i) {}</code></p><p><code>273</code><code>})();</code></p><p><code>274</code><code>&lt;/script&gt;</code></p><p><code>275</code><code>&lt;div id='ZN_7WHWRcRMBs9xWYd'&gt;&lt;!--DO NOT REMOVE-CONTENTS PLACED HERE--&gt;&lt;/div&gt;</code></p><p><code>276</code><code>&lt;!--END WEBSITE FEEDBACK SNIPPET--&gt;</code></p><p><code>277</code><code>          </code></p><p><code>278</code><code>          </code></p><p><code>279</code><code>&lt;div id="glossary" class="glossary"</code></p><p><code>280</code><code>    aria-describedby="glossary-result" aria-hidden="true"&gt;</code></p><p><code>281</code><code>  &lt;button</code></p><p><code>282</code><code>      title="Close glossary"</code></p><p><code>283</code><code>      class="js-glossary-close button button--close js-glossary-toggle usa-button-unstyled"</code></p><p><code>284</code><code>    &gt;&lt;span class="usa-sr-only"&gt;Hide glossary&lt;/span&gt;</code></p><p><code>285</code><code>    &lt;i class="fa fa-times" aria-hidden="true"&gt;&lt;/i&gt;</code></p><p><code>286</code><code>  &lt;/button&gt;</code></p><p><code>287</code><code>  &lt;h4 class="glossary-heading"&gt;Glossary&lt;/h4&gt;</code></p><p><code>288</code><code>  &lt;p&gt;</code></p><p><code>289</code><code>  Study record managers: refer to the &lt;a href="https://classic.clinicaltrials.gov/ct2/manage-recs/resources#DataElement"&gt;&lt;span style="text-decoration:underline"&gt;Data Element Definitions&lt;/span&gt;&lt;/a&gt; if submitting registration or results information.</code></p><p><code>290</code><code>    &lt;/p&gt;</code></p><p><code>291</code><code>  &lt;p&gt;</code></p><p><code>292</code><code>  &lt;label for="glossary-search" class="label"&gt;Search for terms&lt;/label&gt;</code></p><p><code>293</code><code>  &lt;/p&gt;</code></p><p><code>294</code><code>  &lt;span class="clearable-input"&gt;</code></p><p><code>295</code><code>    &lt;input id="glossary-search" class="glossary__search js-glossary-search" type="search"&gt;</code></p><p><code>296</code><code>  &lt;/span&gt;</code></p><p><code>297</code><code>  &lt;div class="glossary__content" id="glossary-result"&gt;</code></p><p><code>298</code><code>    &lt;ul class="js-glossary-list"&gt;&lt;/ul&gt;</code></p><p><code>299</code><code>  &lt;/div&gt;</code></p><p><code>300</code><code>&lt;/div&gt;</code></p><p><code>301</code><code>          </code></p><p><code>302</code><code>          </code></p><p><code>303</code><code>          </code></p><p><code>304</code><code>          </code></p><p><code>305</code><code>&lt;script type="text/javascript" src="/ct2/html/js/working.js"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>306</code><code>&lt;div id="workingDim" class="ct-dim"&gt;</code></p><p><code>307</code><code>  &lt;div id="workingIndicator" class="ct-workingBox" style="text-align:center;vertical-align:middle;"&gt;</code></p><p><code>308</code><code>    &lt;img alt="Working&amp;#8230;" src="/ct2/html/images/working.gif" height="50" &gt;</code></p><p><code>309</code><code>  &lt;/div&gt;</code></p><p><code>310</code><code>&lt;/div&gt;</code></p><p><code>311</code><code>          </code></p><p><code>312</code><code>&lt;div id="wrapper"&gt; </code></p><p><code>313</code><code>&lt;div class="ct-inner_wrapper"&gt;   			&lt;a href="/ct2/home" style='float:left;border-bottom-width:0;min-width:200px;width:29%;'&gt;&lt;img src='/ct2/html/images/ct.gov-nlm-nih-logo.png' alt='ClinicalTrials.gov'/&gt;&lt;/a&gt;</code></p><p><code>314</code><code>          </code></p><p><code>315</code><code>				&lt;div id="hamburger" class="w3-hide-medium w3-hide-large" style="float:right;border-width:0;display:block;margin-left:1em;padding:4px;"</code></p><p><code>316</code><code>			title="Show menus"&gt;</code></p><p><code>317</code><code>			&lt;img src="/ct2/html/images/hamburgerMenuIcon.png" alt="ClinicalTrials.gov Menu" style="max-width:30px;cursor:pointer;" </code></p><p><code>318</code><code>			 onclick="$('#global-nav-popupMenu').toggle();"/&gt;</code></p><p><code>319</code><code>		&lt;/div&gt;</code></p><p><code>320</code><code>		&lt;div id="global-nav-popupMenu" class="w3-hide-medium w3-hide-large w3-modal w3-center" </code></p><p><code>321</code><code>			 style="display:none;" onclick="$('#global-nav-popupMenu').hide();"&gt; 			&lt;div id="global-nav-popupMenu-content" class="w3-modal-content"&gt;</code></p><p><code>322</code><code>				&lt;div class="w3-container"&gt;</code></p><p><code>323</code><code>				    &lt;span onclick="$('#global-nav-popupMenu').hide();"</code></p><p><code>324</code><code>				      class="w3-closebtn"&gt;&amp;times;&lt;/span&gt;</code></p><p><code>325</code><code>					&lt;ul class="sf-menu sf-vertical"&gt;</code></p><p><code>326</code><code>									&lt;li class="first"&gt;&lt;a href="/ct2/search/index"&gt;Find Studies&lt;img src="/ct2/html/images/pulldown.png" alt="Find Studies Menu"&gt;&lt;/a&gt;</code></p><p><code>327</code><code>			&lt;ul&gt;</code></p><p><code>328</code><code>                      &lt;li                  &gt;&lt;a                  href="/ct2/home"&gt;New Search&lt;/a&gt;&lt;/li&gt;</code></p><p><code>329</code><code>                      &lt;li                  &gt;&lt;a         href="/ct2/search/advanced"&gt;Advanced Search&lt;/a&gt;&lt;/li&gt;</code></p><p><code>330</code><code>                      &lt;li                  &gt;&lt;a     href="/ct2/search/browse?brwse=cond_cat"&gt;See Studies by Topic&lt;/a&gt;&lt;/li&gt;</code></p><p><code>331</code><code>                      &lt;li                  &gt;&lt;a             href="/ct2/search/map"&gt;See Studies on Map&lt;/a&gt;&lt;/li&gt;</code></p><p><code>332</code><code>                      &lt;li class="new-group"&gt;&lt;a           href="/ct2/help/how-find/index"&gt;How to Search&lt;/a&gt;&lt;/li&gt;</code></p><p><code>333</code><code>                      &lt;li                  &gt;&lt;a href="/ct2/help/how-use-search-results"&gt;How to Use Search Results&lt;/a&gt;&lt;/li&gt;</code></p><p><code>334</code><code>                      &lt;li                  &gt;&lt;a        href="/ct2/help/how-find/find-study-results"&gt;How to Find Results of Studies&lt;/a&gt;&lt;/li&gt;</code></p><p><code>335</code><code>                      &lt;li                  &gt;&lt;a          href="/ct2/help/how-read-study"&gt;How to Read a Study Record&lt;/a&gt;&lt;/li&gt;</code></p><p><code>336</code><code>			&lt;/ul&gt;</code></p><p><code>337</code><code>			&lt;/li&gt;</code></p><p><code>338</code><code>			&lt;li&gt;&lt;a href="/ct2/about-studies"&gt;About Studies&lt;img src="/ct2/html/images/pulldown.png" alt="About Studies Menu"&gt;&lt;/a&gt;</code></p><p><code>339</code><code>			&lt;ul&gt;</code></p><p><code>340</code><code>                      &lt;li&gt;&lt;a href="/ct2/about-studies/learn"&gt;Learn About Studies&lt;/a&gt;&lt;/li&gt;</code></p><p><code>341</code><code>                      &lt;li&gt;&lt;a  href="/ct2/about-studies/other-sites"&gt;Other Sites About Studies&lt;/a&gt;&lt;/li&gt;</code></p><p><code>342</code><code>                      &lt;li&gt;&lt;a         href="/ct2/about-studies/glossary"&gt;Glossary of Common Site Terms&lt;/a&gt;&lt;/li&gt;</code></p><p><code>343</code><code>			&lt;/ul&gt;</code></p><p><code>344</code><code>			&lt;/li&gt;</code></p><p><code>345</code><code>			&lt;li&gt;&lt;a href="/ct2/manage-recs"&gt;Submit Studies&lt;img src="/ct2/html/images/pulldown.png" alt="Submit Studies Menu"&gt;&lt;/a&gt;</code></p><p><code>346</code><code>			&lt;ul&gt;</code></p><p><code>347</code><code>                      &lt;li&gt;&lt;a                          href="/ct2/manage-recs/submit-study"&gt;Submit Studies to ClinicalTrials.gov PRS&lt;/a&gt;&lt;/li&gt;</code></p><p><code>348</code><code>                      &lt;li&gt;&lt;a                          href="/ct2/manage-recs/background"&gt;Why Should I Register and Submit Results?&lt;/a&gt;&lt;/li&gt;</code></p><p><code>349</code><code>                      &lt;li&gt;&lt;a                                href="/ct2/manage-recs/fdaaa"&gt;FDAAA 801 and the Final Rule&lt;/a&gt;&lt;/li&gt;</code></p><p><code>350</code><code>                      &lt;li class="new-group"&gt;&lt;a    href="/ct2/manage-recs/how-apply"&gt;How to Apply for a PRS Account&lt;/a&gt;&lt;/li&gt;</code></p><p><code>351</code><code>                      &lt;li&gt;&lt;a                        href="/ct2/manage-recs/how-register"&gt;How to Register Your Study&lt;/a&gt;&lt;/li&gt;</code></p><p><code>352</code><code>                      &lt;li&gt;&lt;a                         href="/ct2/manage-recs/how-edit"&gt;How to Edit Your Study Record&lt;/a&gt;&lt;/li&gt;</code></p><p><code>353</code><code>                      &lt;li&gt;&lt;a                   href="/ct2/manage-recs/how-report"&gt;How to Submit Your Results&lt;/a&gt;&lt;/li&gt;</code></p><p><code>354</code><code>                      &lt;li class="new-group"&gt;&lt;a       href="/ct2/manage-recs/faq"&gt;Frequently Asked Questions&lt;/a&gt;&lt;/li&gt;</code></p><p><code>355</code><code>                      &lt;li                  &gt;&lt;a href="/ct2/manage-recs/resources"&gt;Support Materials&lt;/a&gt;&lt;/li&gt;</code></p><p><code>356</code><code>                      &lt;li                  &gt;&lt;a      href="/ct2/manage-recs/present"&gt;Training Materials&lt;/a&gt;&lt;/li&gt;</code></p><p><code>357</code><code>			&lt;/ul&gt;</code></p><p><code>358</code><code>			&lt;/li&gt;</code></p><p><code>359</code><code>			&lt;li&gt;&lt;a href="/ct2/resources"&gt;Resources&lt;img src="/ct2/html/images/pulldown.png" alt="Resources Menu"&gt;&lt;/a&gt;</code></p><p><code>360</code><code>			&lt;ul&gt;</code></p><p><code>361</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/resources/pubs"&gt;Selected Publications&lt;/a&gt;&lt;/li&gt;</code></p><p><code>362</code><code>                      &lt;li                  &gt;&lt;a       href="/ct2/resources/alert"&gt;Clinical Alerts and Advisories&lt;/a&gt;&lt;/li&gt;</code></p><p><code>363</code><code>                      &lt;li                  &gt;&lt;a     href="/ct2/resources/rss"&gt;RSS Feeds&lt;/a&gt;&lt;/li&gt;</code></p><p><code>364</code><code>                      &lt;li class="new-group"&gt;&lt;a href="/ct2/resources/trends"&gt;Trends, Charts, and Maps&lt;/a&gt;&lt;/li&gt;</code></p><p><code>365</code><code>                      &lt;li                  &gt;&lt;a   href="/ct2/resources/download"&gt;Downloading Content for Analysis&lt;/a&gt;&lt;/li&gt;</code></p><p><code>366</code><code>			&lt;/ul&gt;</code></p><p><code>367</code><code>			&lt;/li&gt;</code></p><p><code>368</code><code>			&lt;li class="last"&gt;&lt;a href="/ct2/about-site"&gt;About Site&lt;img src="/ct2/html/images/pulldown.png" alt="About Site Menu"&gt;&lt;/a&gt;</code></p><p><code>369</code><code>			&lt;ul&gt;</code></p><p><code>370</code><code>                      &lt;li class="new-group"&gt;&lt;a href="/ct2/about-site/new"&gt;What's New&lt;/a&gt;&lt;/li&gt;</code></p><p><code>371</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/background"&gt;ClinicalTrials.gov Background&lt;/a&gt;&lt;/li&gt;</code></p><p><code>372</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/results"&gt;About the Results Database&lt;/a&gt;&lt;/li&gt;</code></p><p><code>373</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/history"&gt;History, Policies, and Laws&lt;/a&gt;&lt;/li&gt;</code></p><p><code>374</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/modernization"&gt;ClinicalTrials.gov Modernization&lt;/a&gt;&lt;/li&gt;</code></p><p><code>375</code><code>                      &lt;li                  &gt;&lt;a   href="/ct2/about-site/for-media"&gt;Media/Press Resources&lt;/a&gt;&lt;/li&gt;</code></p><p><code>376</code><code>                      &lt;li class="new-group"&gt;&lt;a          href="/ct2/about-site/link-to"&gt;Linking to This Site&lt;/a&gt;&lt;/li&gt;</code></p><p><code>377</code><code>                      &lt;li                  &gt;&lt;a           href="/ct2/about-site/terms-conditions"&gt;Terms and Conditions&lt;/a&gt;&lt;/li&gt;</code></p><p><code>378</code><code>                      &lt;li                  &gt;&lt;a      href="/ct2/about-site/disclaimer"&gt;Disclaimer&lt;/a&gt;&lt;/li&gt;</code></p><p><code>379</code><code>			&lt;/ul&gt;</code></p><p><code>380</code><code>			&lt;/li&gt;</code></p><p><code>381</code><code>			&lt;li&gt;&lt;a title="Login to the ClinicalTrials.gov Protocol Registration and Results System (PRS)"</code></p><p><code>382</code><code>				href="/ct2/manage-recs/register"&gt;&lt;span style="border-bottom:1px solid;padding-bottom:1px;padding-right:0;"&gt;PRS Login&lt;/span&gt;&lt;/a&gt;</code></p><p><code>383</code><code>			&lt;/li&gt;</code></p><p><code>384</code><code>								&lt;/ul&gt;</code></p><p><code>385</code><code>				&lt;/div&gt;</code></p><p><code>386</code><code>    		&lt;/div&gt;</code></p><p><code>387</code><code>  		&lt;/div&gt;		</code></p><p><code>388</code><code>		</code></p><p><code>389</code><code>&lt;div </code></p><p><code>390</code><code>style="float:right;margin-top:1.5%;" </code></p><p><code>391</code><code>class="w3-hide-small"&gt;</code></p><p><code>392</code><code>	&lt;ul class="sf-menu sf-vertical"&gt;</code></p><p><code>393</code><code>				&lt;li class="first"&gt;&lt;a href="/ct2/search/index"&gt;Find Studies&lt;img src="/ct2/html/images/pulldown.png" alt="Find Studies Menu"&gt;&lt;/a&gt;</code></p><p><code>394</code><code>			&lt;ul&gt;</code></p><p><code>395</code><code>                      &lt;li                  &gt;&lt;a                  href="/ct2/home"&gt;New Search&lt;/a&gt;&lt;/li&gt;</code></p><p><code>396</code><code>                      &lt;li                  &gt;&lt;a         href="/ct2/search/advanced"&gt;Advanced Search&lt;/a&gt;&lt;/li&gt;</code></p><p><code>397</code><code>                      &lt;li                  &gt;&lt;a     href="/ct2/search/browse?brwse=cond_cat"&gt;See Studies by Topic&lt;/a&gt;&lt;/li&gt;</code></p><p><code>398</code><code>                      &lt;li                  &gt;&lt;a             href="/ct2/search/map"&gt;See Studies on Map&lt;/a&gt;&lt;/li&gt;</code></p><p><code>399</code><code>                      &lt;li class="new-group"&gt;&lt;a           href="/ct2/help/how-find/index"&gt;How to Search&lt;/a&gt;&lt;/li&gt;</code></p><p><code>400</code><code>                      &lt;li                  &gt;&lt;a href="/ct2/help/how-use-search-results"&gt;How to Use Search Results&lt;/a&gt;&lt;/li&gt;</code></p><p><code>401</code><code>                      &lt;li                  &gt;&lt;a        href="/ct2/help/how-find/find-study-results"&gt;How to Find Results of Studies&lt;/a&gt;&lt;/li&gt;</code></p><p><code>402</code><code>                      &lt;li                  &gt;&lt;a          href="/ct2/help/how-read-study"&gt;How to Read a Study Record&lt;/a&gt;&lt;/li&gt;</code></p><p><code>403</code><code>			&lt;/ul&gt;</code></p><p><code>404</code><code>			&lt;/li&gt;</code></p><p><code>405</code><code>			&lt;li&gt;&lt;a href="/ct2/about-studies"&gt;About Studies&lt;img src="/ct2/html/images/pulldown.png" alt="About Studies Menu"&gt;&lt;/a&gt;</code></p><p><code>406</code><code>			&lt;ul&gt;</code></p><p><code>407</code><code>                      &lt;li&gt;&lt;a href="/ct2/about-studies/learn"&gt;Learn About Studies&lt;/a&gt;&lt;/li&gt;</code></p><p><code>408</code><code>                      &lt;li&gt;&lt;a  href="/ct2/about-studies/other-sites"&gt;Other Sites About Studies&lt;/a&gt;&lt;/li&gt;</code></p><p><code>409</code><code>                      &lt;li&gt;&lt;a         href="/ct2/about-studies/glossary"&gt;Glossary of Common Site Terms&lt;/a&gt;&lt;/li&gt;</code></p><p><code>410</code><code>			&lt;/ul&gt;</code></p><p><code>411</code><code>			&lt;/li&gt;</code></p><p><code>412</code><code>			&lt;li&gt;&lt;a href="/ct2/manage-recs"&gt;Submit Studies&lt;img src="/ct2/html/images/pulldown.png" alt="Submit Studies Menu"&gt;&lt;/a&gt;</code></p><p><code>413</code><code>			&lt;ul&gt;</code></p><p><code>414</code><code>                      &lt;li&gt;&lt;a                          href="/ct2/manage-recs/submit-study"&gt;Submit Studies to ClinicalTrials.gov PRS&lt;/a&gt;&lt;/li&gt;</code></p><p><code>415</code><code>                      &lt;li&gt;&lt;a                          href="/ct2/manage-recs/background"&gt;Why Should I Register and Submit Results?&lt;/a&gt;&lt;/li&gt;</code></p><p><code>416</code><code>                      &lt;li&gt;&lt;a                                href="/ct2/manage-recs/fdaaa"&gt;FDAAA 801 and the Final Rule&lt;/a&gt;&lt;/li&gt;</code></p><p><code>417</code><code>                      &lt;li class="new-group"&gt;&lt;a    href="/ct2/manage-recs/how-apply"&gt;How to Apply for a PRS Account&lt;/a&gt;&lt;/li&gt;</code></p><p><code>418</code><code>                      &lt;li&gt;&lt;a                        href="/ct2/manage-recs/how-register"&gt;How to Register Your Study&lt;/a&gt;&lt;/li&gt;</code></p><p><code>419</code><code>                      &lt;li&gt;&lt;a                         href="/ct2/manage-recs/how-edit"&gt;How to Edit Your Study Record&lt;/a&gt;&lt;/li&gt;</code></p><p><code>420</code><code>                      &lt;li&gt;&lt;a                   href="/ct2/manage-recs/how-report"&gt;How to Submit Your Results&lt;/a&gt;&lt;/li&gt;</code></p><p><code>421</code><code>                      &lt;li class="new-group"&gt;&lt;a       href="/ct2/manage-recs/faq"&gt;Frequently Asked Questions&lt;/a&gt;&lt;/li&gt;</code></p><p><code>422</code><code>                      &lt;li                  &gt;&lt;a href="/ct2/manage-recs/resources"&gt;Support Materials&lt;/a&gt;&lt;/li&gt;</code></p><p><code>423</code><code>                      &lt;li                  &gt;&lt;a      href="/ct2/manage-recs/present"&gt;Training Materials&lt;/a&gt;&lt;/li&gt;</code></p><p><code>424</code><code>			&lt;/ul&gt;</code></p><p><code>425</code><code>			&lt;/li&gt;</code></p><p><code>426</code><code>			&lt;li&gt;&lt;a href="/ct2/resources"&gt;Resources&lt;img src="/ct2/html/images/pulldown.png" alt="Resources Menu"&gt;&lt;/a&gt;</code></p><p><code>427</code><code>			&lt;ul&gt;</code></p><p><code>428</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/resources/pubs"&gt;Selected Publications&lt;/a&gt;&lt;/li&gt;</code></p><p><code>429</code><code>                      &lt;li                  &gt;&lt;a       href="/ct2/resources/alert"&gt;Clinical Alerts and Advisories&lt;/a&gt;&lt;/li&gt;</code></p><p><code>430</code><code>                      &lt;li                  &gt;&lt;a     href="/ct2/resources/rss"&gt;RSS Feeds&lt;/a&gt;&lt;/li&gt;</code></p><p><code>431</code><code>                      &lt;li class="new-group"&gt;&lt;a href="/ct2/resources/trends"&gt;Trends, Charts, and Maps&lt;/a&gt;&lt;/li&gt;</code></p><p><code>432</code><code>                      &lt;li                  &gt;&lt;a   href="/ct2/resources/download"&gt;Downloading Content for Analysis&lt;/a&gt;&lt;/li&gt;</code></p><p><code>433</code><code>			&lt;/ul&gt;</code></p><p><code>434</code><code>			&lt;/li&gt;</code></p><p><code>435</code><code>			&lt;li class="last"&gt;&lt;a href="/ct2/about-site"&gt;About Site&lt;img src="/ct2/html/images/pulldown.png" alt="About Site Menu"&gt;&lt;/a&gt;</code></p><p><code>436</code><code>			&lt;ul&gt;</code></p><p><code>437</code><code>                      &lt;li class="new-group"&gt;&lt;a href="/ct2/about-site/new"&gt;What's New&lt;/a&gt;&lt;/li&gt;</code></p><p><code>438</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/background"&gt;ClinicalTrials.gov Background&lt;/a&gt;&lt;/li&gt;</code></p><p><code>439</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/results"&gt;About the Results Database&lt;/a&gt;&lt;/li&gt;</code></p><p><code>440</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/history"&gt;History, Policies, and Laws&lt;/a&gt;&lt;/li&gt;</code></p><p><code>441</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/modernization"&gt;ClinicalTrials.gov Modernization&lt;/a&gt;&lt;/li&gt;</code></p><p><code>442</code><code>                      &lt;li                  &gt;&lt;a   href="/ct2/about-site/for-media"&gt;Media/Press Resources&lt;/a&gt;&lt;/li&gt;</code></p><p><code>443</code><code>                      &lt;li class="new-group"&gt;&lt;a          href="/ct2/about-site/link-to"&gt;Linking to This Site&lt;/a&gt;&lt;/li&gt;</code></p><p><code>444</code><code>                      &lt;li                  &gt;&lt;a           href="/ct2/about-site/terms-conditions"&gt;Terms and Conditions&lt;/a&gt;&lt;/li&gt;</code></p><p><code>445</code><code>                      &lt;li                  &gt;&lt;a      href="/ct2/about-site/disclaimer"&gt;Disclaimer&lt;/a&gt;&lt;/li&gt;</code></p><p><code>446</code><code>			&lt;/ul&gt;</code></p><p><code>447</code><code>			&lt;/li&gt;</code></p><p><code>448</code><code>			&lt;li&gt;&lt;a title="Login to the ClinicalTrials.gov Protocol Registration and Results System (PRS)"</code></p><p><code>449</code><code>				href="/ct2/manage-recs/register"&gt;&lt;span style="border-bottom:1px solid;padding-bottom:1px;padding-right:0;"&gt;PRS Login&lt;/span&gt;&lt;/a&gt;</code></p><p><code>450</code><code>			&lt;/li&gt;</code></p><p><code>451</code><code>				&lt;/ul&gt;</code></p><p><code>452</code><code>    &lt;div style="clear:both;"&gt;&lt;/div&gt;</code></p><p><code>453</code><code>&lt;/div&gt;</code></p><p><code>454</code><code>&lt;div style="clear:both;"&gt;&lt;/div&gt;</code></p><p><code>455</code><code>          </code></p><p><code>456</code><code>&lt;/div&gt; </code></p><p><code>457</code><code>&lt;div class="ct-outer_breadcrumb w3-container"&gt;</code></p><p><code>458</code><code>	&lt;div id="breadcrumb"&gt;</code></p><p><code>459</code><code>    &lt;ul class="ct-horz-list w3-left"&gt;</code></p><p><code>460</code><code>			&lt;li&gt;&lt;a href="/ct2/home"&gt;Home&lt;/a&gt;&lt;/li&gt;</code></p><p><code>461</code><code>												&lt;li&gt;&lt;a href="/ct2/results?term=NCT04065399&amp;amp;draw=2&amp;amp;rank=1"&gt;Search Results&lt;/a&gt;&lt;/li&gt;</code></p><p><code>462</code><code>										&lt;li&gt;Study Record Detail&lt;/li&gt;</code></p><p><code>463</code><code>    &lt;/ul&gt;</code></p><p><code>464</code><code>    &lt;div id="savedStudies" class="w3-right"&gt;</code></p><p><code>465</code><code>  	&lt;div id="cart" style="cursor:pointer;" onclick="location.href=('/ct2/results'+cartToURL()); showWorking();"&gt;</code></p><p><code>466</code><code>  	&lt;button class="ct-savedStudiesEnabled" id="open-cart-link" type="button" </code></p><p><code>467</code><code>  		onclick="location.href=('/ct2/results'+cartToURL()); showWorking();"</code></p><p><code>468</code><code>  		title="Show previously saved studies."&gt;Saved Studies&lt;/button&gt;</code></p><p><code>469</code><code>  	&lt;/div&gt;</code></p><p><code>470</code><code>&lt;/div&gt;</code></p><p><code>471</code><code>&lt;script type="text/javascript" src="/ct2/html/js/cart.js?v=48"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>472</code><code>          </code></p><p><code>473</code><code>		&lt;script type="text/javascript"&gt;</code></p><p><code>474</code><code>	$(document).ready(function(){</code></p><p><code>475</code><code>		$("input#saved").prop( 'checked', (inCart("NCT04065399")&gt;=0));</code></p><p><code>476</code><code>	});</code></p><p><code>477</code><code>&lt;/script&gt;</code></p><p><code>478</code><code>		&lt;div class="w3-right" style="margin-right: 1em;"&gt;</code></p><p><code>479</code><code>			&lt;label for="saved" title="Add or Remove this study in the Saved Studies list"&gt;&lt;input type="checkbox" id="saved" name="NCT04065399" onchange="updateCart('NCT04065399');" style="margin-left:1em;"&gt; Save this study &lt;/label&gt;</code></p><p><code>480</code><code>		&lt;/div&gt;</code></p><p><code>481</code><code>		&lt;div id="maxSavedStudies-popup" class="w3-modal" style="cursor:pointer;border:2px groove" onclick="$('#maxSavedStudies-popup').hide();"&gt;</code></p><p><code>482</code><code>	&lt;div id="maxSavedStudies-popup-content" class="w3-modal-content"&gt;</code></p><p><code>483</code><code>		&lt;div class="w3-display-container" style="border:1px solid #ccc;background-color:#eee;"&gt;</code></p><p><code>484</code><code>			&lt;form&gt;</code></p><p><code>485</code><code>			&lt;div class="w3-center" style="font-size:large;font-weight:bold;padding:3ex 1.5em;"&gt;</code></p><p><code>486</code><code>				&lt;img src="/ct2/html/images/warning.png" alt="Maximum Saved Studies Reached" style="max-width:1.0rem;cursor:pointer;"/&gt;</code></p><p><code>487</code><code>			    &lt;b&gt;Warning&lt;/b&gt;</code></p><p><code>488</code><code>				&lt;div style="margin-top:1ex;margin-bottom:0.5ex;"&gt;You have reached the maximum number of saved studies (100).&lt;/div&gt;</code></p><p><code>489</code><code>				&lt;div&gt;Please remove one or more studies before adding more.&lt;/div&gt;</code></p><p><code>490</code><code>			&lt;/div&gt;</code></p><p><code>491</code><code>		</code></p><p><code>492</code><code>			&lt;div class="w3-center" style="padding-bottom:1.5ex"&gt;</code></p><p><code>493</code><code>			  &lt;input class="ct-searchButton" type="button" style="opacity:1.0;font-weight:bold;font-size:inherit;padding:1.1ex 1em;" onclick="$('#maxSavedStudies-popup').hide();" value="Close" title="Close this dialog"/&gt;</code></p><p><code>494</code><code>			&lt;/div&gt;</code></p><p><code>495</code><code>			&lt;/form&gt;</code></p><p><code>496</code><code>		&lt;/div&gt;</code></p><p><code>497</code><code>	&lt;/div&gt;</code></p><p><code>498</code><code>&lt;/div&gt;</code></p><p><code>499</code><code>          </code></p><p><code>500</code><code>	&lt;/div&gt;</code></p><p><code>501</code><code>&lt;/div&gt;</code></p><p><code>502</code><code>          </code></p><p><code>503</code><code>&lt;div style="clear:both;"&gt;&lt;/div&gt;</code></p><p><code>504</code><code>          </code></p><p><code>505</code><code>&lt;div id="main-content" tabindex='-1'&gt;</code></p><p><code>506</code><code>	</code></p><p><code>507</code><code>	</code></p><p><code>508</code><code>		&lt;div class="tr-indent2"&gt;</code></p><p><code>509</code><code>        	&lt;div id="search-results" class="tr-search-results"&gt;</code></p><p><code>510</code><code>					&lt;div class="tr-results-summary"&gt;</code></p><p><code>511</code><code>				Trial record &lt;strong&gt;1 of 1&lt;/strong&gt; for:</code></p><p><code>512</code><code>		        &amp;nbsp;&amp;nbsp;  NCT04065399	        &lt;/div&gt;</code></p><p><code>513</code><code>	            &lt;div class="tr-results-nav"&gt;</code></p><p><code>514</code><code>         &lt;span class="grayed_fore_color"&gt;Previous Study&lt;/span&gt;         | &lt;a href="/ct2/results?term=NCT04065399&amp;amp;draw=2&amp;amp;rank=1" class="tr-return-link" &gt;Return to List&lt;/a&gt; |</code></p><p><code>515</code><code>         &lt;span class="grayed_fore_color"&gt;Next Study&lt;/span&gt; 		&lt;/div&gt;</code></p><p><code>516</code><code>	&lt;/div&gt;</code></p><p><code>517</code><code>	&lt;h1 class="tr-h1 ct-sans-serif"&gt;A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation (AUGMENT-101)&lt;/h1&gt;</code></p><p><code>518</code><code>          </code></p><p><code>519</code><code>  &lt;div class="w3-row"&gt;</code></p><p><code>520</code><code>    &lt;div class="w3-col m6"&gt;       &lt;div class="usa-alert usa-alert-warning" style="clear:both;margin:2ex 2em;"&gt;</code></p><p><code>521</code><code>        &lt;table&gt;</code></p><p><code>522</code><code>          &lt;tr&gt;</code></p><p><code>523</code><code>            &lt;td style="width:5%"&gt;</code></p><p><code>524</code><code>              &lt;img src="/ct2/html/images/warning.png" style="width:1.3em;" alt=""/&gt;</code></p><p><code>525</code><code>            &lt;/td&gt;</code></p><p><code>526</code><code>            &lt;td style="padding-right:2em;"&gt;</code></p><p><code>527</code><code>              The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.</code></p><p><code>528</code><code>                              &lt;a href="/ct2/about-studies/learn#Considerations"&gt;Know the risks and potential benefits&lt;/a&gt; of clinical studies and talk to your health care provider before participating.</code></p><p><code>529</code><code>                            Read our &lt;a href="/ct2/about-site/disclaimer"&gt;disclaimer&lt;/a&gt; for details.</code></p><p><code>530</code><code>            &lt;/td&gt;</code></p><p><code>531</code><code>          &lt;/tr&gt;</code></p><p><code>532</code><code>        &lt;/table&gt;</code></p><p><code>533</code><code>      &lt;/div&gt;      &lt;/div&gt; </code></p><p><code>534</code><code>&lt;!--</code></p><p><code>535</code><code>    &lt;div style="float:right;margin-right:4em"&gt;ClinicalTrials.gov Identifier: NCT04065399&lt;/div&gt;</code></p><p><code>536</code><code>--&gt;</code></p><p><code>537</code><code>    &lt;div class="w3-col m1"&gt;&amp;nbsp;&lt;/div&gt; </code></p><p><code>538</code><code>    &lt;div class="w3-col m5"&gt;       &lt;table style="width:95%"&gt;</code></p><p><code>539</code><code>        &lt;tr&gt;</code></p><p><code>540</code><code>          &lt;td&gt;ClinicalTrials.gov Identifier: NCT04065399&lt;/td&gt;</code></p><p><code>541</code><code>        &lt;/tr&gt;</code></p><p><code>542</code><code>        &lt;tr&gt;</code></p><p><code>543</code><code>          &lt;td&gt;</code></p><p><code>544</code><code>                          </code></p><p><code>545</code><code>                          </code></p><p><code>546</code><code>                                  &lt;div class="tr-status tr-recruiting-colors"&gt;</code></p><p><code>547</code><code>                                            &lt;span style="display:inline;" class="term" data-term="Recruitment Status" title="Show definition"&gt;Recruitment Status &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Recruitment Status" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; : </code></p><p><code>548</code><code>                                        Recruiting</code></p><p><code>549</code><code>                                                                  </code></p><p><code>550</code><code>                                              </code></p><p><code>551</code><code>            &lt;div style="font-size:inherit"&gt;</code></p><p><code>552</code><code>            &lt;span style="display:inline;" class="term" data-term="First Posted" title="Show definition"&gt;First Posted &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="First Posted" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; : August 22, 2019&lt;/div&gt;</code></p><p><code>553</code><code>                        &lt;div style="font-size:inherit"&gt;</code></p><p><code>554</code><code>            &lt;span style="display:inline;" class="term" data-term="Last Update Posted" title="Show definition"&gt;Last Update Posted &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Last Update Posted" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; : August 21, 2023&lt;/div&gt;</code></p><p><code>555</code><code>          </code></p><p><code>556</code><code>                          &lt;div style="margin-top:1ex; font-size:14px"&gt;</code></p><p><code>557</code><code>                &lt;span style="color:black;"&gt;See &lt;/span&gt;&lt;a href="#contacts"&gt;</code></p><p><code>558</code><code>                &lt;span class="ct-header2" style="font-size:inherit;"&gt; Contacts and Locations&lt;/span&gt;&lt;/a&gt;</code></p><p><code>559</code><code>              &lt;/div&gt;</code></p><p><code>560</code><code>            </code></p><p><code>561</code><code>                                    &lt;/div&gt;</code></p><p><code>562</code><code>          &lt;/td&gt;</code></p><p><code>563</code><code>        &lt;/tr&gt;</code></p><p><code>564</code><code>      &lt;/table&gt;</code></p><p><code>565</code><code>          </code></p><p><code>566</code><code>      &lt;!-- CTGDEV-1242 --&gt;</code></p><p><code>567</code><code>      &lt;div style="width:95%; margin-top:10px; padding: 0px 3px;"&gt;</code></p><p><code>568</code><code>        &lt;div style="padding: 15px 15px; background-color: #eff6fb; border: 5px #aacdec; border-style: solid none none none;"&gt;</code></p><p><code>569</code><code>        </code></p><p><code>570</code><code>          &lt;a href="https://clinicaltrials.gov/study/NCT04065399" target="_blank"&gt;View this study on the modernized ClinicalTrials.gov&lt;/a&gt;</code></p><p><code>571</code><code>                            &lt;/div&gt;</code></p><p><code>572</code><code>      &lt;/div&gt;</code></p><p><code>573</code><code>    &lt;/div&gt;    &lt;!-- div.w3-col.m5 --&gt;</code></p><p><code>574</code><code>  &lt;/div&gt;</code></p><p><code>575</code><code>          </code></p><p><code>576</code><code>  &lt;!-- CTGDEV-1242 --&gt;</code></p><p><code>577</code><code>  &lt;!--</code></p><p><code>578</code><code>  &lt;div style="float: right; width:41.66666%; margin-top:1rem; margin-left: 3rem; margin-bottom: 1rem;"&gt;</code></p><p><code>579</code><code>    &lt;div style="width:95%; background-color: #eff6fb; "&gt;</code></p><p><code>580</code><code>      &lt;div style="width:100%; height:.5rem; background-color: #aacdec;"&gt;&lt;/div&gt;</code></p><p><code>581</code><code>      &lt;div style="padding: 15px 15px;"&gt;</code></p><p><code>582</code><code>        &lt;a href="https://beta.clinicaltrials.gov/study/NCT04065399" target="_blank"&gt;View Record on Beta&lt;/a&gt;</code></p><p><code>583</code><code>      &lt;/div&gt;</code></p><p><code>584</code><code>    &lt;/div&gt;</code></p><p><code>585</code><code>  &lt;/div&gt;</code></p><p><code>586</code><code>  --&gt;</code></p><p><code>587</code><code>          </code></p><p><code>588</code><code>          </code></p><p><code>589</code><code>                &lt;div class="tr-info-title"&gt;Sponsor:&lt;/div&gt;</code></p><p><code>590</code><code>                &lt;div class="tr-info-text" id="sponsor"&gt; Syndax Pharmaceuticals &lt;/div&gt;</code></p><p><code>591</code><code>          </code></p><p><code>592</code><code>                              &lt;div class="tr-info-title"&gt;Information provided by (Responsible Party):&lt;/div&gt;</code></p><p><code>593</code><code>                &lt;div class="tr-info-text" id="responsibleparty"&gt;Syndax Pharmaceuticals&lt;/div&gt;</code></p><p><code>594</code><code>              	&lt;/div&gt;</code></p><p><code>595</code><code>&lt;br&gt;</code></p><p><code>596</code><code>          </code></p><p><code>597</code><code>    </code></p><p><code>598</code><code>&lt;div id="tabs"&gt;</code></p><p><code>599</code><code>    &lt;ul id="tab-links"&gt;</code></p><p><code>600</code><code>		&lt;li id="full-text"  class="current"&gt;Study Details     &lt;/li&gt;</code></p><p><code>601</code><code>		&lt;li id="tabular"   &gt;&lt;a href="/ct2/show/record/NCT04065399?term=NCT04065399&amp;amp;draw=2&amp;amp;rank=1" &gt;Tabular View&lt;/a&gt;&lt;/li&gt;</code></p><p><code>602</code><code>  					&lt;li id="results"   &gt;&lt;a href="/ct2/show/results/NCT04065399?term=NCT04065399&amp;amp;draw=2&amp;amp;rank=1"&gt;No Results Posted&lt;/a&gt;&lt;/li&gt;</code></p><p><code>603</code><code>						&lt;li id="disclaimer"&gt;&lt;a title="Disclaimer - opens new window"  href="/ct2/about-site/disclaimer" onclick="openNewWindow('/ct2/about-site/disclaimer'); return false"</code></p><p><code>604</code><code>&gt;Disclaimer&lt;/a&gt;&lt;/li&gt;</code></p><p><code>605</code><code>		&lt;li id="howtoread"&gt;&lt;a title="How to Read a Study Record - opens new window"  href="/ct2/help/how-read-study" onclick="openNewWindow('/ct2/help/how-read-study'); return false"</code></p><p><code>606</code><code>&gt;How to Read a Study Record&lt;/a&gt;&lt;/li&gt;</code></p><p><code>607</code><code>    &lt;/ul&gt;</code></p><p><code>608</code><code>&lt;/div&gt;  &lt;!--</code></p><p><code>609</code><code>&lt;div style="background-color:#f6f6f6;margin-top:5.0ex;padding-bottom:1.5ex;"&gt; &lt;/div&gt;</code></p><p><code>610</code><code>--&gt;</code></p><p><code>611</code><code>		</code></p><p><code>612</code><code>	&lt;div id="tab-body"&gt;</code></p><p><code>613</code><code>		&lt;div class="tr-indent2" style="background-color:white;"&gt;</code></p><p><code>614</code><code>						  </code></p><p><code>615</code><code>&lt;!-- purpose_section --&gt;</code></p><p><code>616</code><code>&lt;div class="tr-indent1" style="margin-top:1ex"&gt;</code></p><p><code>617</code><code>          </code></p><p><code>618</code><code>&lt;div class="tr-subsection"&gt;</code></p><p><code>619</code><code>	&lt;div class="ct-header2"&gt;&lt;a id="studydesc"&gt;&lt;/a&gt;Study Description&lt;/div&gt;</code></p><p><code>620</code><code>	&lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>621</code><code>	&lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>622</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>623</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>624</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>625</code><code>&lt;/button&gt;</code></p><p><code>626</code><code>          </code></p><p><code>627</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>628</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>629</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>630</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>631</code><code>          </code></p><p><code>632</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>633</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>634</code><code>    </code></p><p><code>635</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>636</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>637</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>638</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>639</code><code>  &lt;/div&gt;</code></p><p><code>640</code><code>&lt;/div&gt;</code></p><p><code>641</code><code>&lt;/div&gt;</code></p><p><code>642</code><code>          </code></p><p><code>643</code><code>&lt;div class="tr-indent2" style="margin-top:2ex"&gt;</code></p><p><code>644</code><code>          </code></p><p><code>645</code><code>  &lt;div class="ct-body3"&gt;Brief Summary:&lt;/div&gt;</code></p><p><code>646</code><code>  &lt;div class="ct-body3 tr-indent2"&gt;&lt;p style="margin-top:1ex; margin-bottom:1ex;"&gt;Phase 1 dose escalation will determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of SNDX-5613 in participants with acute leukemia.&lt;/p&gt;</code></p><p><code>647</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;In Phase 2, participants will be enrolled in 3 indication-specific expansion cohorts to determine the efficacy, short- and long-term safety, and tolerability of SNDX-5613.&lt;/p&gt;&lt;/div&gt;&lt;br/&gt;</code></p><p><code>648</code><code>          </code></p><p><code>649</code><code>    &lt;!-- condition, intervention, phase summary table --&gt;</code></p><p><code>650</code><code>  &lt;table class="ct-data_table tr-data_table" border="1" style="margin:auto;width:80%;"&gt;</code></p><p><code>651</code><code>    &lt;tr style="text-align:left;"&gt;</code></p><p><code>652</code><code>            &lt;th class="ct-header3 tr-pale_banner_color"&gt;</code></p><p><code>653</code><code>&lt;span style="display:inline;" class="term" data-term="Condition/disease" title="Show definition"&gt;Condition or disease &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Condition/disease" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt;       &lt;/th&gt;</code></p><p><code>654</code><code>                  &lt;th class="ct-header3 tr-pale_banner_color"&gt;</code></p><p><code>655</code><code>&lt;span style="display:inline;" class="term" data-term="Intervention/treatment" title="Show definition"&gt;Intervention/treatment &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Intervention/treatment" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt;       &lt;/th&gt;</code></p><p><code>656</code><code>                  &lt;th class="ct-header3 tr-pale_banner_color"&gt;</code></p><p><code>657</code><code>&lt;span style="display:inline;" class="term" data-term="Phase" title="Show definition"&gt;Phase &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Phase" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt;       &lt;/th&gt;</code></p><p><code>658</code><code>          &lt;/tr&gt;</code></p><p><code>659</code><code>    &lt;tr style="text-align:left;vertical-align:top;"&gt;</code></p><p><code>660</code><code>            &lt;td class="ct-body3"&gt;</code></p><p><code>661</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Acute Myeloid Leukemia&lt;/span&gt;</code></p><p><code>662</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Acute Lymphoblastic Leukemia&lt;/span&gt;</code></p><p><code>663</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Mixed Lineage Acute Leukemia&lt;/span&gt;</code></p><p><code>664</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Mixed Phenotype Acute Leukemia&lt;/span&gt;</code></p><p><code>665</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Acute Leukemia of Ambiguous Lineage&lt;/span&gt;</code></p><p><code>666</code><code>              &lt;/td&gt;</code></p><p><code>667</code><code>                  &lt;td class="ct-body3"&gt;</code></p><p><code>668</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Drug: SNDX-5613&lt;/span&gt;</code></p><p><code>669</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Drug: cobicistat&lt;/span&gt;</code></p><p><code>670</code><code>              &lt;/td&gt;</code></p><p><code>671</code><code>                  &lt;td class="ct-body3" style="white-space:nowrap;"&gt;</code></p><p><code>672</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Phase 1&lt;/span&gt;</code></p><p><code>673</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Phase 2&lt;/span&gt;</code></p><p><code>674</code><code>              &lt;/td&gt;</code></p><p><code>675</code><code>          &lt;/tr&gt;</code></p><p><code>676</code><code>  &lt;/table&gt;</code></p><p><code>677</code><code>  &lt;br/&gt;</code></p><p><code>678</code><code>  </code></p><p><code>679</code><code>      &lt;span style="display:inline;" class="term" data-term="Expanded Access" title="Show definition"&gt;Expanded Access &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Expanded Access"&gt;&lt;/i&gt;&lt;/span&gt;: An investigational treatment associated with this study is &lt;span style="color:green"&gt;available&lt;/span&gt; outside the clinical trial. &amp;nbsp;</code></p><p><code>680</code><code>          &lt;a class="ct-header3 tr-tr-study-link" title="Show expanded access study" href="/ct2/show/NCT05918913" </code></p><p><code>681</code><code>      onclick="openPopupWindow('/ct2/show/NCT05918913',false); return false;"&gt;More info ...&lt;/a&gt;</code></p><p><code>682</code><code>        &lt;br/&gt;</code></p><p><code>683</code><code>    &lt;br/&gt;</code></p><p><code>684</code><code>  </code></p><p><code>685</code><code>      &lt;a id="desc"&gt;&lt;/a&gt;</code></p><p><code>686</code><code>          </code></p><p><code>687</code><code>    </code></p><p><code>688</code><code>    &lt;!-- detailed description --&gt;</code></p><p><code>689</code><code>    &lt;div id="COLLAPSE-DetailedDesc" class="COLLAPSE"  style="margin-bottom:2ex;"&gt;</code></p><p><code>690</code><code>      &lt;div class="ct-body3"&gt;&lt;a id="detaileddesc"&gt;&lt;/a&gt;Detailed Description:&lt;/div&gt;</code></p><p><code>691</code><code>      &lt;div class="ct-body3 tr-indent2"&gt;&lt;p style="margin-top:1ex; margin-bottom:1ex;"&gt;Phase 1: Oral SNDX-5613; sequential cohorts of escalating dose levels of SNDX-5613 to identify the MTD and RP2D. Participants will be enrolled in one of six dose-escalation arms:&lt;/p&gt;</code></p><p><code>692</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Arm A: Participants not receiving any strong cytochrome P450 3A4 (CYP3A4) inhibitor/inducers or fluconazole.&lt;/p&gt;</code></p><p><code>693</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Arm B: Participants receiving itraconazole, ketoconazole, posaconazole, or voriconazole (strong CYP3A4 inhibitors) for antifungal prophylaxis.&lt;/p&gt;</code></p><p><code>694</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Arm C: Participants receiving SNDX-5613 and cobicistat.&lt;/p&gt;</code></p><p><code>695</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Arm D: Participants receiving fluconazole (moderate CYP3A4 inhibitor) for antifungal prophylaxis.&lt;/p&gt;</code></p><p><code>696</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Arm E: Participants not receiving any weak, moderate, or strong CYP3A4 inhibitors/inducers.&lt;/p&gt;</code></p><p><code>697</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Arm F: Participants receiving isavuconazole (moderate CYP3A4 inhibitor) for antifungal prophylaxis.&lt;/p&gt;</code></p><p><code>698</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;In Phase 2, participants will be enrolled in 3 indication-specific expansion cohorts to determine the efficacy, short- and long-term safety, and tolerability of SNDX-5613:&lt;/p&gt;</code></p><p><code>699</code><code>  &lt;ul style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>700</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Cohort 2A: Participants with MLLr acute lymphoblastic leukemia (ALL)/mixed phenotype acute leukemia (MPAL)&lt;/li&gt;</code></p><p><code>701</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Cohort 2B: Participants with MLLr AML&lt;/li&gt;</code></p><p><code>702</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Cohort 2C: Participants with NPM1c AML&lt;/li&gt;</code></p><p><code>703</code><code>  &lt;/ul&gt;&lt;/div&gt;</code></p><p><code>704</code><code>    &lt;/div&gt;</code></p><p><code>705</code><code>&lt;/div&gt; </code></p><p><code>706</code><code>&lt;div class="tr-subsection"&gt;</code></p><p><code>707</code><code>  &lt;div class="ct-header2"&gt;&lt;a id="studydesign"&gt;&lt;/a&gt;Study Design&lt;/div&gt;</code></p><p><code>708</code><code>  &lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>709</code><code>  &lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>710</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>711</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>712</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>713</code><code>&lt;/button&gt;</code></p><p><code>714</code><code>          </code></p><p><code>715</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>716</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>717</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>718</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>719</code><code>          </code></p><p><code>720</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>721</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>722</code><code>    </code></p><p><code>723</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>724</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>725</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>726</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>727</code><code>  &lt;/div&gt;</code></p><p><code>728</code><code>&lt;/div&gt;</code></p><p><code>729</code><code>&lt;/div&gt;</code></p><p><code>730</code><code>          </code></p><p><code>731</code><code>  &lt;p&gt;</code></p><p><code>732</code><code>  &lt;table class="ct-layout_table tr-tableStyle tr-studyInfo" style="margin-bottom:2ex;"&gt;</code></p><p><code>733</code><code>   &lt;caption&gt;Layout table for study information&lt;/caption&gt;</code></p><p><code>734</code><code>   &lt;thead&gt;</code></p><p><code>735</code><code>    &lt;tr&gt;</code></p><p><code>736</code><code>      &lt;th id="studyInfoColTitle"&gt;&lt;/th&gt;</code></p><p><code>737</code><code>      &lt;th id="studyInfoColData"&gt;&lt;/th&gt;</code></p><p><code>738</code><code>    &lt;/tr&gt;</code></p><p><code>739</code><code>    &lt;/thead&gt;</code></p><p><code>740</code><code>    &lt;tbody&gt;</code></p><p><code>741</code><code>        &lt;tr&gt;</code></p><p><code>742</code><code>      &lt;td headers="studyInfoColTitle"&gt;</code></p><p><code>743</code><code>&lt;span style="display:inline;" class="term" data-term="Study Type" title="Show definition"&gt;Study Type &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Study Type" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :&lt;/td&gt;</code></p><p><code>744</code><code>      &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;</code></p><p><code>745</code><code>        Interventional</code></p><p><code>746</code><code>                &amp;nbsp;(Clinical Trial)</code></p><p><code>747</code><code>                </code></p><p><code>748</code><code>        </code></p><p><code>749</code><code>      &lt;/td&gt;</code></p><p><code>750</code><code>    &lt;/tr&gt;</code></p><p><code>751</code><code>                    &lt;tr&gt;</code></p><p><code>752</code><code>      &lt;td headers="studyInfoColTitle"&gt;Estimated</code></p><p><code>753</code><code>&lt;span style="display:inline;" class="term" data-term="Enrollment" title="Show definition"&gt;Enrollment &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Enrollment" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :&lt;/td&gt;</code></p><p><code>754</code><code>      &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;440 participants&lt;/td&gt;</code></p><p><code>755</code><code>    &lt;/tr&gt;</code></p><p><code>756</code><code>                &lt;tr&gt;</code></p><p><code>757</code><code>            &lt;td headers="studyInfoColTitle"&gt;Allocation:&lt;/td&gt;</code></p><p><code>758</code><code>            &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;N/A&lt;/td&gt;</code></p><p><code>759</code><code>    &lt;/tr&gt;</code></p><p><code>760</code><code>        &lt;tr&gt;</code></p><p><code>761</code><code>            &lt;td headers="studyInfoColTitle"&gt;Intervention Model:&lt;/td&gt;</code></p><p><code>762</code><code>            &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;Sequential Assignment&lt;/td&gt;</code></p><p><code>763</code><code>    &lt;/tr&gt;</code></p><p><code>764</code><code>        &lt;tr&gt;</code></p><p><code>765</code><code>            &lt;td headers="studyInfoColTitle"&gt;Intervention Model Description:&lt;/td&gt;</code></p><p><code>766</code><code>            &lt;td headers="studyInfoColData" style="padding-left:1em"&gt; Phase 1 will employ an accelerated titration design. The dose escalation will follow a modified Fibonacci sequence.&lt;/td&gt;</code></p><p><code>767</code><code>    &lt;/tr&gt;</code></p><p><code>768</code><code>        &lt;tr&gt;</code></p><p><code>769</code><code>            &lt;td headers="studyInfoColTitle"&gt;Masking:&lt;/td&gt;</code></p><p><code>770</code><code>            &lt;td headers="studyInfoColData" style="padding-left:1em"&gt; None (Open Label)&lt;/td&gt;</code></p><p><code>771</code><code>    &lt;/tr&gt;</code></p><p><code>772</code><code>        &lt;tr&gt;</code></p><p><code>773</code><code>            &lt;td headers="studyInfoColTitle"&gt;Primary Purpose:&lt;/td&gt;</code></p><p><code>774</code><code>            &lt;td headers="studyInfoColData" style="padding-left:1em"&gt; Treatment&lt;/td&gt;</code></p><p><code>775</code><code>    &lt;/tr&gt;</code></p><p><code>776</code><code>                    &lt;tr&gt;</code></p><p><code>777</code><code>&lt;!--</code></p><p><code>778</code><code>      &lt;td headers="studyInfoColTitle" style="padding-top:2ex;"&gt;Official Title:&lt;/td&gt;</code></p><p><code>779</code><code>--&gt;</code></p><p><code>780</code><code>      &lt;td headers="studyInfoColTitle"&gt;Official Title:&lt;/td&gt;</code></p><p><code>781</code><code>      &lt;td headers="studyInfoColData" style="padding-left:1em;"&gt;A Phase 1/2, Open-label, Dose-Escalation and Dose-Expansion Cohort Study of SNDX-5613 in Patients With Relapsed/Refractory Leukemias, Including Those Harboring an MLL/KMT2A Gene Rearrangement or Nucleophosmin 1 (NPM1) Mutation&lt;/td&gt;</code></p><p><code>782</code><code>    &lt;/tr&gt;</code></p><p><code>783</code><code>    </code></p><p><code>784</code><code>            &lt;tr&gt;</code></p><p><code>785</code><code>        &lt;td headers="studyInfoColTitle"&gt;  Actual &lt;span style="display:inline;" class="term" data-term="Study Start Date" title="Show definition"&gt;Study Start Date &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Study Start Date" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :&lt;/td&gt;</code></p><p><code>786</code><code>        &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;November 5, 2019&lt;/td&gt;</code></p><p><code>787</code><code>      &lt;/tr&gt;</code></p><p><code>788</code><code>                  &lt;tr&gt;</code></p><p><code>789</code><code>        &lt;td headers="studyInfoColTitle"&gt;  Estimated &lt;span style="display:inline;" class="term" data-term="Primary Completion Date" title="Show definition"&gt;Primary Completion Date &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Primary Completion Date" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :&lt;/td&gt;</code></p><p><code>790</code><code>        &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;April 30, 2025&lt;/td&gt;</code></p><p><code>791</code><code>      &lt;/tr&gt;</code></p><p><code>792</code><code>                  &lt;tr&gt;</code></p><p><code>793</code><code>        &lt;td headers="studyInfoColTitle"&gt;  Estimated &lt;span style="display:inline;" class="term" data-term="Study Completion Date" title="Show definition"&gt;Study Completion Date &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Study Completion Date" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :&lt;/td&gt;</code></p><p><code>794</code><code>        &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;April 30, 2026&lt;/td&gt;</code></p><p><code>795</code><code>      &lt;/tr&gt;</code></p><p><code>796</code><code>            &lt;/tbody&gt;</code></p><p><code>797</code><code>    &lt;/table&gt;</code></p><p><code>798</code><code>          </code></p><p><code>799</code><code>    &lt;!-- NLM links --&gt;</code></p><p><code>800</code><code>&lt;p&gt;</code></p><p><code>801</code><code>&lt;div class="tr-indent2"&gt;</code></p><p><code>802</code><code>  &lt;div class="usa-alert usa-alert-warning nlm-info"&gt;</code></p><p><code>803</code><code>    &lt;strong&gt;Resource links provided by the National Library of Medicine&lt;/strong&gt;</code></p><p><code>804</code><code>    &lt;img src="/ct2/html/images/NIH_NLM_ABRV_BLK_4.png" style="width:5em; float:right;" alt=""/&gt;</code></p><p><code>805</code><code>    &lt;p&gt;</code></p><p><code>806</code><code>    &lt;p&gt;</code></p><p><code>807</code><code>          </code></p><p><code>808</code><code>  </code></p><p><code>809</code><code>    &lt;!-- medline links --&gt;</code></p><p><code>810</code><code>  &lt;div style="margin-bottom:2ex;"&gt;</code></p><p><code>811</code><code>    &lt;a class="tr-study-link" href="https://medlineplus.gov/" title="MedlinePlus" onclick="openNewWindow('https://medlineplus.gov/'); return false"&gt;MedlinePlus&lt;/a&gt; related topics:</code></p><p><code>812</code><code>    	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://medlineplus.gov/genesandgenetherapy.html" title="Genes&amp;#160;and&amp;#160;Gene&amp;#160;Therapy at MedlinePlus" onclick="openNewWindow('https://medlineplus.gov/genesandgenetherapy.html'); return false"&gt;Genes&amp;#160;and&amp;#160;Gene&amp;#160;Therapy&lt;/a&gt;</code></p><p><code>813</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://medlineplus.gov/leukemia.html" title="Leukemia at MedlinePlus" onclick="openNewWindow('https://medlineplus.gov/leukemia.html'); return false"&gt;Leukemia&lt;/a&gt;</code></p><p><code>814</code><code>	          &lt;/div&gt;</code></p><p><code>815</code><code>  </code></p><p><code>816</code><code>    &lt;!-- SIS links --&gt;</code></p><p><code>817</code><code>  &lt;div style="margin-bottom:2ex;"&gt;</code></p><p><code>818</code><code>    &lt;a class="tr-study-link" href="https://dailymed.nlm.nih.gov/dailymed/" title="Dailymed Portal" onclick="openNewWindow('https://dailymed.nlm.nih.gov/dailymed/'); return false"&gt;Drug Information&lt;/a&gt; </code></p><p><code>819</code><code>          </code></p><p><code>820</code><code>                                          available for:</code></p><p><code>821</code><code>    </code></p><p><code>822</code><code>    	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=human&amp;query=Cobicistat" title="Cobicistat at Dailymed Portal" onclick="openNewWindow('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=human&amp;query=Cobicistat'); return false"&gt;Cobicistat&lt;/a&gt;</code></p><p><code>823</code><code>	          &lt;/div&gt;</code></p><p><code>824</code><code>      					      </code></p><p><code>825</code><code>    &lt;!-- ORD links --&gt;</code></p><p><code>826</code><code>  &lt;div style="margin-bottom:2ex;"&gt;</code></p><p><code>827</code><code>    &lt;a class="tr-study-link" href="https://rarediseases.info.nih.gov/gard" title="Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/gard'); return false"&gt;Genetic and Rare Diseases Information Center&lt;/a&gt; resources:</code></p><p><code>828</code><code>    	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/6544/acute-graft-versus-host-disease" title="Acute&amp;#160;Graft&amp;#160;Versus&amp;#160;Host&amp;#160;Disease at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/6544/acute-graft-versus-host-disease'); return false"&gt;Acute&amp;#160;Graft&amp;#160;Versus&amp;#160;Host&amp;#160;Disease&lt;/a&gt;</code></p><p><code>829</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/522/acute-lymphoblastic-leukemia" title="Acute&amp;#160;Lymphoblastic&amp;#160;Leukemia at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/522/acute-lymphoblastic-leukemia'); return false"&gt;Acute&amp;#160;Lymphoblastic&amp;#160;Leukemia&lt;/a&gt;</code></p><p><code>830</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/3329/lymphoblastic-lymphoma" title="Lymphoblastic&amp;#160;Lymphoma at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/3329/lymphoblastic-lymphoma'); return false"&gt;Lymphoblastic&amp;#160;Lymphoma&lt;/a&gt;</code></p><p><code>831</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/8226/myeloid-leukemia" title="Myeloid&amp;#160;Leukemia at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/8226/myeloid-leukemia'); return false"&gt;Myeloid&amp;#160;Leukemia&lt;/a&gt;</code></p><p><code>832</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/12757/acute-myeloid-leukemia" title="Acute&amp;#160;Myeloid&amp;#160;Leukemia at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/12757/acute-myeloid-leukemia'); return false"&gt;Acute&amp;#160;Myeloid&amp;#160;Leukemia&lt;/a&gt;</code></p><p><code>833</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/537/acute-non-lymphoblastic-leukemia" title="Acute&amp;#160;Non&amp;#160;Lymphoblastic&amp;#160;Leukemia at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/537/acute-non-lymphoblastic-leukemia'); return false"&gt;Acute&amp;#160;Non&amp;#160;Lymphoblastic&amp;#160;Leukemia&lt;/a&gt;</code></p><p><code>834</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/8638/acute-leukemia-of-ambiguous-lineage" title="Acute&amp;#160;Leukemia&amp;#160;of&amp;#160;Ambiguous&amp;#160;Lineage at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/8638/acute-leukemia-of-ambiguous-lineage'); return false"&gt;Acute&amp;#160;Leukemia&amp;#160;of&amp;#160;Ambiguous&amp;#160;Lineage&lt;/a&gt;</code></p><p><code>835</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/6946/lymphosarcoma" title="Lymphosarcoma at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/6946/lymphosarcoma'); return false"&gt;Lymphosarcoma&lt;/a&gt;</code></p><p><code>836</code><code>	          &lt;/div&gt;</code></p><p><code>837</code><code>  </code></p><p><code>838</code><code>  </code></p><p><code>839</code><code>  &lt;!-- Ropr Link --&gt;</code></p><p><code>840</code><code>&lt;!-- Commented out RoPR</code></p><p><code>841</code><code>  --&gt;</code></p><p><code>842</code><code>          </code></p><p><code>843</code><code>  &lt;div style="margin-bottom:2ex;"&gt;</code></p><p><code>844</code><code>  &lt;a class="tr-study-link" href="/ct2/info/fdalinks" title="Show FDA resources page" onclick="openNewWindow('/ct2/info/fdalinks'); return false"&gt;U.S. FDA Resources&lt;/a&gt;</code></p><p><code>845</code><code>  &lt;/div&gt;</code></p><p><code>846</code><code>          </code></p><p><code>847</code><code>  &lt;/div&gt;</code></p><p><code>848</code><code>&lt;/div&gt;</code></p><p><code>849</code><code>          </code></p><p><code>850</code><code>          </code></p><p><code>851</code><code>  </code></p><p><code>852</code><code>  &lt;br/&gt;</code></p><p><code>853</code><code>    &lt;/div&gt;</code></p><p><code>854</code><code>          </code></p><p><code>855</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>856</code><code>    		&lt;div class="tr-subsection"&gt;</code></p><p><code>857</code><code>		    		    	&lt;div class="ct-header2"&gt;&lt;a id="armgroup"&gt;&lt;/a&gt;Arms and Interventions&lt;/div&gt;</code></p><p><code>858</code><code>		    		    &lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>859</code><code>			&lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>860</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>861</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>862</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>863</code><code>&lt;/button&gt;</code></p><p><code>864</code><code>          </code></p><p><code>865</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>866</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>867</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>868</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>869</code><code>          </code></p><p><code>870</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>871</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>872</code><code>    </code></p><p><code>873</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>874</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>875</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>876</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>877</code><code>  &lt;/div&gt;</code></p><p><code>878</code><code>&lt;/div&gt;</code></p><p><code>879</code><code>		&lt;/div&gt;</code></p><p><code>880</code><code>	</code></p><p><code>881</code><code>    &lt;div style="padding-left:.8em; padding-right:1.2em;text-align:left;"&gt;</code></p><p><code>882</code><code>        &lt;p&gt;</code></p><p><code>883</code><code>    &lt;table class="ct-data_table tr-data_table" style="padding:5px;width:100%;border-width:1px;"&gt;</code></p><p><code>884</code><code>      &lt;thead&gt;</code></p><p><code>885</code><code>      &lt;tr style="text-align:left;"&gt;</code></p><p><code>886</code><code>        &lt;th class="ct-header3 tr-pale_banner_color" style="width:50%;"&gt;</code></p><p><code>887</code><code>            				&lt;span style="display:inline;" class="term" data-term="Arm" title="Show definition"&gt;Arm &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Arm" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; 			        &lt;/th&gt;</code></p><p><code>888</code><code>                &lt;th class="ct-header3 tr-pale_banner_color"&gt;</code></p><p><code>889</code><code>			&lt;span style="display:inline;" class="term" data-term="Intervention/treatment" title="Show definition"&gt;Intervention/treatment &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Intervention/treatment" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt;         &lt;/th&gt;</code></p><p><code>890</code><code>              &lt;/tr&gt;</code></p><p><code>891</code><code>      &lt;/thead&gt;</code></p><p><code>892</code><code>      &lt;tbody&gt;</code></p><p><code>893</code><code>            &lt;tr style="text-align:left;vertical-align:top;"&gt;</code></p><p><code>894</code><code>        &lt;td class="ct-body3"&gt;</code></p><p><code>895</code><code>          Experimental: Experimental: SNDX-5613</code></p><p><code>896</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;&lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Phase 1: Oral SNDX-5613; sequential cohorts of escalating dose levels of SNDX-5613 to identify the MTD and RP2D. Participants will be enrolled in 1 of 6 dose-escalation arms:&lt;/p&gt;</code></p><p><code>897</code><code>  &lt;ul style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>898</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Arm A: Participants not receiving any strong CYP3A4 inhibitor/inducers or fluconazole&lt;/li&gt;</code></p><p><code>899</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Arm B: Participants receiving any strong CYP3A4 inhibitors for antifungal prophylaxis&lt;/li&gt;</code></p><p><code>900</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Arm C: Participants receiving SNDX-5613 and cobicistat&lt;/li&gt;</code></p><p><code>901</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Arm D: Participants receiving fluconazole for antifungal prophylaxis&lt;/li&gt;</code></p><p><code>902</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Arm E: Participants not receiving any weak, moderate, or strong CYP3A4 inhibitors/inducers&lt;/li&gt;</code></p><p><code>903</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Arm F: Participants receiving isavuconazole for antifungal prophylaxis&lt;/li&gt;</code></p><p><code>904</code><code>  &lt;/ul&gt;</code></p><p><code>905</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Phase 2: Oral SNDX-5613; Following the determination of the RP2D in Phase 1, 3 indication-specific expansion cohorts will be enrolled as follows:&lt;/p&gt;</code></p><p><code>906</code><code>  &lt;ul style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>907</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Cohort 2A: Participants with MLLr ALL/MPAL&lt;/li&gt;</code></p><p><code>908</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Cohort 2B: Participants with MLLr AML&lt;/li&gt;</code></p><p><code>909</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Cohort 2C: Participants with NPM1c AML&lt;/li&gt;</code></p><p><code>910</code><code>  &lt;/ul&gt;&lt;/div&gt;</code></p><p><code>911</code><code>        &lt;/td&gt;</code></p><p><code>912</code><code>                &lt;td class="ct-body3"&gt;</code></p><p><code>913</code><code>                      Drug: SNDX-5613</code></p><p><code>914</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;SNDX-5613 orally&lt;/div&gt;&lt;br/&gt;</code></p><p><code>915</code><code>                      Drug: cobicistat</code></p><p><code>916</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Phase 1 Arm C participants will receive 150 mg cobicistat daily.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>917</code><code>                  &lt;/td&gt;</code></p><p><code>918</code><code>              &lt;/tr&gt;</code></p><p><code>919</code><code>            &lt;/tbody&gt;</code></p><p><code>920</code><code>    &lt;/table&gt;</code></p><p><code>921</code><code>          &lt;/div&gt;</code></p><p><code>922</code><code>    &lt;br/&gt;</code></p><p><code>923</code><code>          </code></p><p><code>924</code><code>    </code></p><p><code>925</code><code>    &lt;!-- more details --&gt;</code></p><p><code>926</code><code>  &lt;br/&gt;</code></p><p><code>927</code><code>  &lt;div class="tr-subsection"&gt;</code></p><p><code>928</code><code>	  &lt;div class="ct-header2"&gt;&lt;a id="outcomemeasures"&gt;&lt;/a&gt;Outcome Measures&lt;/div&gt;</code></p><p><code>929</code><code>	  &lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>930</code><code>	  &lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>931</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>932</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>933</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>934</code><code>&lt;/button&gt;</code></p><p><code>935</code><code>          </code></p><p><code>936</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>937</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>938</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>939</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>940</code><code>          </code></p><p><code>941</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>942</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>943</code><code>    </code></p><p><code>944</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>945</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>946</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>947</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>948</code><code>  &lt;/div&gt;</code></p><p><code>949</code><code>&lt;/div&gt;</code></p><p><code>950</code><code>  &lt;/div&gt;</code></p><p><code>951</code><code>  &lt;br/&gt;</code></p><p><code>952</code><code>  &lt;div class="tr-indent3" style="margin-right:1em;"&gt;</code></p><p><code>953</code><code>          </code></p><p><code>954</code><code>        &lt;!-- primary outcomes --&gt;</code></p><p><code>955</code><code>    &lt;div class="ct-body3"&gt;</code></p><p><code>956</code><code>&lt;span style="display:inline;" class="term" data-term="Primary Outcome Measure" title="Show definition"&gt;Primary Outcome Measures &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Primary Outcome Measure" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :</code></p><p><code>957</code><code>      &lt;ol style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>958</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Occurrence of dose-limiting toxicities (DLTs) (Phase 1) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 1 year&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Assessed by the NCI CTCAE version 5.0 (Phase 1)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>959</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Frequency, duration, and severity of treatment-emergent adverse events (TEAEs) (Phase 1) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 1 year&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Assessed by the NCI CTCAE version 5.0 (Phase 1)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>960</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Frequency, duration, and severity of treatment-related TEAEs (TRAEs) (Phase 1) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 1 year&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Assessed by the NCI CTCAE version 5.0 (Phase 1)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>961</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Frequency, duration, and severity of serious adverse events (SAEs) (Phase 1) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 1 year&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Assessed by the NCI CTCAE version 5.0 (Phase 1)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>962</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Cmax (Phase 1) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 1 year&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Maximum plasma concentration (CMAX) of SNDX-5613 (Phase 1)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>963</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Tmax (Phase 1) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 1 year&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Time to observed maximum plasma concentration of SNDX-5613 (Phase 1)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>964</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;AUC0-t (Phase 1) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 1 year&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Area under the plasma concentration-time curve from time 0 to time of last measurable concentration of SNDX-5613 (Phase 1)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>965</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;AUC0-24 (Phase 1) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 1 year&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Area under the plasma concentration-time curve from time 0 to 24 hours (Phase 1)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>966</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;CL/F (Phase 1) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 1 year&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Apparent oral clearance of SNDX-5613 (Phase 1)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>967</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Vz/F (Phase 1) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 1 year&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Apparent volume of distribution of SNDX-5613 (Phase 1)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>968</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;t1/2 (Phase 1) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 1 year&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Terminal phase half-life of SNDX-5613 (Phase 1)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>969</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Complete remission (CR) rate (Phase 2) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 3 years&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To assess the CR rate (CR+CRh). (Phase 2)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>970</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Frequency and severity of adverse events (AEs) (Phase 2) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 3 years&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Assessed by the NCI CTCAE version 5.0 (Phase 2)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>971</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Frequency and severity of serious adverse events (SAEs) (Phase 2) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 3 years&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Assessed by the NCI CTCAE version 5.0 (Phase 2)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>972</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Frequency, duration, and severity of treatment-emergent adverse events (TEAEs) (Phase 2) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 3 years&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Assessed by the NCI CTCAE version 5.0 (Phase 2)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>973</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Frequency, duration, and severity of treatment-related TEAEs (TRAEs) (Phase 2) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 3 years&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Assessed by the NCI CTCAE version 5.0 (Phase 2)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>974</code><code>            &lt;/ol&gt;</code></p><p><code>975</code><code>    &lt;/div&gt;</code></p><p><code>976</code><code>    &lt;br/&gt;</code></p><p><code>977</code><code>    </code></p><p><code>978</code><code>        &lt;!-- secondary outcomes --&gt;</code></p><p><code>979</code><code>    &lt;div class="ct-body3"  style="margin-right:1em;"&gt;</code></p><p><code>980</code><code>&lt;span style="display:inline;" class="term" data-term="Secondary Outcome Measure" title="Show definition"&gt;Secondary Outcome Measures &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Secondary Outcome Measure" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :</code></p><p><code>981</code><code>      &lt;ol style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>982</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Composite definition of complete remission (CRc) Rate (Phase 2) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 3 years&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To assess the CRc rate. (Phase 2)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>983</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Complete remission with partial hematologic recovery (CR+CRh) rate after 4 weeks of therapy (Phase 2) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 19 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To assess the CR (CR+CRh) rate after 4 weeks of therapy. (Phase 2)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>984</code><code>            &lt;li style="margin-top:0.7ex;"&gt;BORR (CRc+ partial remission [PR]). (Phase 2) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 3 years&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To assess the best overall remission rate (BORR) of SNDX-5613 (Phase 2)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>985</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Median RFS (Phase 2) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 3 years&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To assess relapse-free survival of SNDX-5613 (Phase 2)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>986</code><code>            &lt;li style="margin-top:0.7ex;"&gt;TTR (Phase 2) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 34 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To assess the time to response (TTR) of SNDX-5613 (Phase 2)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>987</code><code>            &lt;li style="margin-top:0.7ex;"&gt;DOR (Phase 2) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 3 years&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To assess the duration of response (DOR) of SNDX-5613 (Phase 2)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>988</code><code>            &lt;li style="margin-top:0.7ex;"&gt;OS (Phase 2) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 5 years&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To assess overall survival of SNDX-5613 (Phase 2)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>989</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Cmax (Phase 2) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 3 years&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Maximum plasma concentration (CMAX) of SNDX-5613 (Phase 2)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>990</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Tmax (Phase 2) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 3 years&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Time to observed maximum plasma concentration of SNDX-5613 (Phase 2)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>991</code><code>            &lt;li style="margin-top:0.7ex;"&gt;AUC0-t (Phase 2) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 3 years&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Area under the plasma concentration-time curve from time 0 to time of last measurable concentration of SNDX-5613 (Phase 2)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>992</code><code>            &lt;li style="margin-top:0.7ex;"&gt;AUC0-24 (Phase 2) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 3 years&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Area under the plasma concentration-time curve from time 0 to 24 hours (Phase 2)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>993</code><code>            &lt;li style="margin-top:0.7ex;"&gt;CL/F (Phase 2) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 3 years&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Apparent oral clearance of SNDX-5613 (Phase 2)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>994</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Vz/F (Phase 2) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 3 years&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Apparent volume of distribution of SNDX-5613 (Phase 2)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>995</code><code>            &lt;li style="margin-top:0.7ex;"&gt;t1/2 (Phase 2) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Approximately 3 years&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;Terminal phase half-life of SNDX-5613 (Phase 2)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>996</code><code>            &lt;/ol&gt;</code></p><p><code>997</code><code>    &lt;/div&gt;</code></p><p><code>998</code><code>    &lt;br/&gt;</code></p><p><code>999</code><code>    </code></p><p><code>1000</code><code>    </code></p><p><code>1001</code><code>    </code></p><p><code>1002</code><code>  &lt;/div&gt;</code></p><p><code>1003</code><code>  </code></p><p><code>1004</code><code>			  </code></p><p><code>1005</code><code>&lt;!-- eligibility_section --&gt;</code></p><p><code>1006</code><code>&lt;div class="tr-indent1" style="margin-top:3ex; border:1px solid white"&gt;</code></p><p><code>1007</code><code>&lt;div class="tr-subsection"&gt;</code></p><p><code>1008</code><code>	&lt;div class="ct-header2"&gt;&lt;a id="eligibility"&gt;&lt;/a&gt;Eligibility Criteria&lt;/div&gt;</code></p><p><code>1009</code><code>	&lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>1010</code><code>	&lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>1011</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>1012</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>1013</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>1014</code><code>&lt;/button&gt;</code></p><p><code>1015</code><code>          </code></p><p><code>1016</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>1017</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>1018</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>1019</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>1020</code><code>          </code></p><p><code>1021</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>1022</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>1023</code><code>    </code></p><p><code>1024</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>1025</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>1026</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>1027</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>1028</code><code>  &lt;/div&gt;</code></p><p><code>1029</code><code>&lt;/div&gt;</code></p><p><code>1030</code><code>&lt;/div&gt;</code></p><p><code>1031</code><code>&lt;br/&gt;</code></p><p><code>1032</code><code>          </code></p><p><code>1033</code><code>&lt;p&gt;</code></p><p><code>1034</code><code>  &lt;div class="tr-indent2 usa-alert usa-alert-warning nlm-info"&gt;</code></p><p><code>1035</code><code>    &lt;strong&gt;Information from the National Library of Medicine&lt;/strong&gt;</code></p><p><code>1036</code><code>    &lt;img src="/ct2/html/images/NIH_NLM_ABRV_BLK_4.png" style="width:5em; float:right;" alt=""/&gt;</code></p><p><code>1037</code><code>    &lt;p&gt;</code></p><p><code>1038</code><code>    &lt;p&gt;</code></p><p><code>1039</code><code>    &lt;em&gt;Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, &lt;a href="/ct2/about-studies/learn" title="Learn About Clinical Studies"&gt;&lt;u&gt;Learn About Clinical Studies.&lt;/u&gt;&lt;/a&gt;</code></p><p><code>1040</code><code>    &lt;/em&gt;</code></p><p><code>1041</code><code>  &lt;/div&gt;</code></p><p><code>1042</code><code>          </code></p><p><code>1043</code><code>          </code></p><p><code>1044</code><code>  &lt;br/&gt;</code></p><p><code>1045</code><code>  &lt;div class="tr-indent2"&gt;</code></p><p><code>1046</code><code>    &lt;table class="ct-layout_table tr-tableStyle tr-studyInfo"&gt;</code></p><p><code>1047</code><code>      &lt;caption&gt;Layout table for eligibility information&lt;/caption&gt;</code></p><p><code>1048</code><code>      &lt;thead&gt;</code></p><p><code>1049</code><code>        &lt;tr&gt;</code></p><p><code>1050</code><code>          &lt;th id="elgType"&gt;&lt;/th&gt;</code></p><p><code>1051</code><code>          &lt;th id="elgData"&gt;&lt;/th&gt;</code></p><p><code>1052</code><code>        &lt;/tr&gt;</code></p><p><code>1053</code><code>      &lt;/thead&gt;</code></p><p><code>1054</code><code>      &lt;tbody&gt;</code></p><p><code>1055</code><code>            &lt;tr&gt;</code></p><p><code>1056</code><code>        &lt;td headers="elgType" class="ct-nowrap"&gt;Ages Eligible for Study: &amp;nbsp; &lt;/td&gt;</code></p><p><code>1057</code><code>        &lt;td headers="elgData" style="padding-left:1em"&gt;30 Days and older &amp;nbsp; (Child, Adult, Older Adult)&lt;/td&gt;</code></p><p><code>1058</code><code>      &lt;/tr&gt;</code></p><p><code>1059</code><code>                  &lt;tr&gt;</code></p><p><code>1060</code><code>        &lt;td headers="elgType" class="ct-nowrap"&gt;Sexes Eligible for Study: &amp;nbsp; &lt;/td&gt;</code></p><p><code>1061</code><code>        &lt;td headers="elgData" style="padding-left:1em"&gt;All&lt;/td&gt;</code></p><p><code>1062</code><code>      &lt;/tr&gt;</code></p><p><code>1063</code><code>                              &lt;tr&gt;</code></p><p><code>1064</code><code>        &lt;td headers="elgType" class="ct-nowrap"&gt;Accepts Healthy Volunteers: &amp;nbsp; &lt;/td&gt;</code></p><p><code>1065</code><code>        &lt;td headers="elgData" style="padding-left:1em"&gt;No&lt;/td&gt;</code></p><p><code>1066</code><code>      &lt;/tr&gt;</code></p><p><code>1067</code><code>                  &lt;/tbody&gt;</code></p><p><code>1068</code><code>    &lt;/table&gt;</code></p><p><code>1069</code><code>          </code></p><p><code>1070</code><code>    </code></p><p><code>1071</code><code>        &lt;div class="ct-header3" style="margin-top:2ex"&gt;Criteria&lt;/div&gt;</code></p><p><code>1072</code><code>    &lt;div class="tr-indent2"&gt;&lt;p style="margin-top:1ex; margin-bottom:1ex;"&gt;Inclusion Criteria:&lt;/p&gt;</code></p><p><code>1073</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Participants must have active acute leukemia (bone marrow blasts &amp;#8805;5% or reappearance of blasts in peripheral blood) as defined by the National Comprehensive Cancer Network (NCCN) in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines&amp;#174;) for Acute Lymphoblastic Leukemia (Version 1.2020) and Acute Myeloid Leukemia (Version 3.2020), or acute leukemia harboring an MLL rearrangement, NUP98 rearrangement, or NPM1c mutation that have detectable disease in the bone marrow.&lt;/p&gt;</code></p><p><code>1074</code><code>  &lt;ol style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>1075</code><code>    &lt;li style="margin-top:0.7ex;"&gt;</code></p><p><code>1076</code><code>      &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Phase 1:&lt;/p&gt;</code></p><p><code>1077</code><code>      &lt;ul style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>1078</code><code>        &lt;li style="margin-top:0.7ex;"&gt;Arm A: Participants not receiving any strong CYP3A4 inhibitor/inducers or fluconazole.&lt;/li&gt;</code></p><p><code>1079</code><code>        &lt;li style="margin-top:0.7ex;"&gt;Arm B: Participants receiving itraconazole, ketoconazole, posaconazole, or voriconazole (strong CYP3A4 inhibitors) for antifungal prophylaxis.&lt;/li&gt;</code></p><p><code>1080</code><code>        &lt;li style="margin-top:0.7ex;"&gt;Arm C: Participants receiving SNDX-5613 in combination with cobicistat.&lt;/li&gt;</code></p><p><code>1081</code><code>        &lt;li style="margin-top:0.7ex;"&gt;Arm D: Participants receiving fluconazole (moderate CYP3A4 inhibitor).&lt;/li&gt;</code></p><p><code>1082</code><code>        &lt;li style="margin-top:0.7ex;"&gt;Arm E: Participants not receiving any weak, moderate, or strong CYP3A4 inhibitors/inducers.&lt;/li&gt;</code></p><p><code>1083</code><code>        &lt;li style="margin-top:0.7ex;"&gt;Arm F: Participants receiving isavuconazole (moderate CYP3A4 inhibitor) for antifungal prophylaxis.&lt;/li&gt;</code></p><p><code>1084</code><code>      &lt;/ul&gt;</code></p><p><code>1085</code><code>    &lt;/li&gt;</code></p><p><code>1086</code><code>    &lt;li style="margin-top:0.7ex;"&gt;</code></p><p><code>1087</code><code>      &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Phase 2:&lt;/p&gt;</code></p><p><code>1088</code><code>      &lt;ul style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>1089</code><code>        &lt;li style="margin-top:0.7ex;"&gt;Cohort 2A: Documented R/R ALL/MPAL with an MLLr translocation.&lt;/li&gt;</code></p><p><code>1090</code><code>        &lt;li style="margin-top:0.7ex;"&gt;Cohort 2B: Documented R/R AML with an MLLr translocation.&lt;/li&gt;</code></p><p><code>1091</code><code>        &lt;li style="margin-top:0.7ex;"&gt;Cohort 2C: Documented R/R AML with NPM1c.&lt;/li&gt;</code></p><p><code>1092</code><code>      &lt;/ul&gt;</code></p><p><code>1093</code><code>    &lt;/li&gt;</code></p><p><code>1094</code><code>    &lt;li style="margin-top:0.7ex;"&gt;White blood cell count below 25,000/ microliter at time of enrollment. Participants may receive cytoreduction prior to enrollment per protocol-specified criteria.&lt;/li&gt;</code></p><p><code>1095</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Male or female participants aged &amp;#8805;30 days old.&lt;/li&gt;</code></p><p><code>1096</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Eastern Cooperative Oncology Group (ECOG) performance status score 0-2 or Karnofsky/Lansky score &amp;#8805;50.&lt;/li&gt;</code></p><p><code>1097</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Any prior treatment-related toxicities resolved to &amp;#8804;Grade 1 prior to enrollment, with the exception of &amp;#8804;Grade 2 neuropathy or alopecia.&lt;/li&gt;</code></p><p><code>1098</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Radiation Therapy: At least 60 days from prior total body irradiation (TBI), craniospinal radiation and/or &amp;#8805;50% radiation of the pelvis, or at least 14 days from local palliative radiation therapy (small port).&lt;/li&gt;</code></p><p><code>1099</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Stem Cell Infusion: At least 60 days must have elapsed from hematopoietic stem cell transplant and at least 4 weeks must have elapsed from donor lymphocyte infusion.&lt;/li&gt;</code></p><p><code>1100</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Immunotherapy: At least 42 days since prior immunotherapy, including tumor vaccines and checkpoint inhibitors, and at least 21 days since receipt of chimeric antigen receptor therapy or other modified T cell therapy.&lt;/li&gt;</code></p><p><code>1101</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Antileukemia Therapy: At least 14 days, or 5 half-lives, whichever is shorter, since the completion of antileukemic therapy.&lt;/li&gt;</code></p><p><code>1102</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Hematopoietic Growth Factors: At least 7 days since the completion of therapy with short-acting hematopoietic growth factors and 14 days with long-acting growth factors.&lt;/li&gt;</code></p><p><code>1103</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Biologics: At least 90 days, or 5 half-lives, whichever is shorter, since the completion of therapy with an antineoplastic biologic agent.&lt;/li&gt;</code></p><p><code>1104</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Steroids: At least 7 days since systemic glucocorticoid therapy, unless receiving physiologic dosing (equivalent to &amp;#8804;10 mg prednisone daily) or cytoreductive therapy.&lt;/li&gt;</code></p><p><code>1105</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Adequate organ function.&lt;/li&gt;</code></p><p><code>1106</code><code>    &lt;li style="margin-top:0.7ex;"&gt;If of childbearing potential, willing to use a highly effective method of contraception or double barrier method from the time of enrollment through 120 days following the last study drug dose.&lt;/li&gt;</code></p><p><code>1107</code><code>  &lt;/ol&gt;</code></p><p><code>1108</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Exclusion Criteria:&lt;/p&gt;</code></p><p><code>1109</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Participants meeting any of the following criteria are not eligible for study participation:&lt;/p&gt;</code></p><p><code>1110</code><code>  &lt;ol style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>1111</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Active diagnosis of acute promyelocytic leukemia.&lt;/li&gt;</code></p><p><code>1112</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Isolated extramedullary relapse.&lt;/li&gt;</code></p><p><code>1113</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Active central nervous system disease (cytologic, such as any blasts on cytospin, or radiographic).&lt;/li&gt;</code></p><p><code>1114</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Detectable human immunodeficiency virus (HIV) viral load within the previous 6 months. Participants with a known history of HIV 1/2 antibodies must have viral load testing prior to study enrollment.&lt;/li&gt;</code></p><p><code>1115</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Hepatitis B or C.&lt;/li&gt;</code></p><p><code>1116</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Pregnant or nursing women.&lt;/li&gt;</code></p><p><code>1117</code><code>    &lt;li style="margin-top:0.7ex;"&gt;</code></p><p><code>1118</code><code>      &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Cardiac Disease:&lt;/p&gt;</code></p><p><code>1119</code><code>      &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Any of the following within the 6 months prior to study entry: myocardial infarction, uncontrolled/unstable angina, congestive heart failure (New York Heart Association Classification Class &amp;#8805;II), life-threatening, uncontrolled arrhythmia, cerebrovascular accident, or transient ischemic attack.&lt;/p&gt;</code></p><p><code>1120</code><code>      &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;- Corrected QT interval (QTc) &amp;gt;450 milliseconds.&lt;/p&gt;</code></p><p><code>1121</code><code>    &lt;/li&gt;</code></p><p><code>1122</code><code>    &lt;li style="margin-top:0.7ex;"&gt;</code></p><p><code>1123</code><code>      &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Gastrointestinal Disease:&lt;/p&gt;</code></p><p><code>1124</code><code>      &lt;ul style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>1125</code><code>        &lt;li style="margin-top:0.7ex;"&gt;any gastrointestinal issue of the upper GI tract that might affect oral drug absorption or ingestion (that is, gastric bypass, gastroparesis, etc).&lt;/li&gt;</code></p><p><code>1126</code><code>        &lt;li style="margin-top:0.7ex;"&gt;Cirrhosis with a Child-Pugh score of B or C.&lt;/li&gt;</code></p><p><code>1127</code><code>      &lt;/ul&gt;</code></p><p><code>1128</code><code>    &lt;/li&gt;</code></p><p><code>1129</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Graft-Versus-Host Disease (GVHD): Signs or symptoms of acute or chronic GVHD &amp;gt;Grade 0 within 4 weeks of enrollment. All transplant participants must have been off all systemic immunosuppressive therapy and calcineurin inhibitors for at least 4 weeks prior to enrollment. Participants may be on physiological doses of steroids.&lt;/li&gt;</code></p><p><code>1130</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Concurrent malignancy in the previous 2 years with the exception of basal cell carcinoma of the skin, squamous cell carcinoma of the skin, or carcinoma in situ (for example, breast carcinoma, cervical cancer in situ, melanoma in situ) treated with potentially curative therapy, or concurrent low-grade lymphoma, that is asymptomatic and lacks bulky disease and shows no evidence of progression, and for which the participant is not receiving any systemic therapy or radiation.&lt;/li&gt;</code></p><p><code>1131</code><code>    &lt;li style="margin-top:0.7ex;"&gt;In Phase 1 and Phase 2: Participants requiring the concurrent use of medications known or suspected to prolong the QT/QTc interval, with the exception of drugs with low risk of QT/QTc prolongation that are used as standard supportive therapies (for example, diphenhydramine, famotidine, ondansetron, Bactrim) and the azoles permitted in the relevant arms of Phase 1.&lt;/li&gt;</code></p><p><code>1132</code><code>  &lt;/ol&gt;&lt;/div&gt;</code></p><p><code>1133</code><code>    </code></p><p><code>1134</code><code>  &lt;/div&gt;</code></p><p><code>1135</code><code>          </code></p><p><code>1136</code><code>  &lt;/div&gt;</code></p><p><code>1137</code><code>          </code></p><p><code>1138</code><code>			  </code></p><p><code>1139</code><code>&lt;!-- location_section --&gt;</code></p><p><code>1140</code><code>&lt;a id="contacts"&gt;&lt;/a&gt;</code></p><p><code>1141</code><code>&lt;div class="tr-indent1" style="margin-top:3ex"&gt;</code></p><p><code>1142</code><code>&lt;div class="tr-subsection"&gt;</code></p><p><code>1143</code><code>	&lt;div class="ct-header2"&gt;&lt;a id="contactlocation"&gt;&lt;/a&gt;Contacts and Locations&lt;/div&gt;</code></p><p><code>1144</code><code>	&lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>1145</code><code>	&lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>1146</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>1147</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>1148</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>1149</code><code>&lt;/button&gt;</code></p><p><code>1150</code><code>          </code></p><p><code>1151</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>1152</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>1153</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>1154</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>1155</code><code>          </code></p><p><code>1156</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>1157</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>1158</code><code>    </code></p><p><code>1159</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>1160</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>1161</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>1162</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>1163</code><code>  &lt;/div&gt;</code></p><p><code>1164</code><code>&lt;/div&gt;</code></p><p><code>1165</code><code>&lt;/div&gt;</code></p><p><code>1166</code><code>&lt;br/&gt;</code></p><p><code>1167</code><code>          </code></p><p><code>1168</code><code>          </code></p><p><code>1169</code><code>&lt;div class="tr-indent2" style="margin-top:2ex"&gt;</code></p><p><code>1170</code><code>          </code></p><p><code>1171</code><code>&lt;!--</code></p><p><code>1172</code><code>Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. </code></p><p><code>1173</code><code>To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. </code></p><p><code>1174</code><code>For general information, see &lt;a href="/ct2/about-studies/learn" target="def_win" onClick="openNewWindow('/ct2/about-studies/learn'); return false;" title="Learn About Clinical Studies - opens new window"&gt;&lt;u&gt;Learn About Clinical Studies.&lt;/u&gt;&lt;/a&gt;</code></p><p><code>1175</code><code>&lt;br/&gt;</code></p><p><code>1176</code><code>--&gt;</code></p><p><code>1177</code><code>          </code></p><p><code>1178</code><code>  </code></p><p><code>1179</code><code>  &lt;div class="usa-alert usa-alert-warning nlm-info"&gt;</code></p><p><code>1180</code><code>    &lt;strong&gt;Information from the National Library of Medicine&lt;/strong&gt;</code></p><p><code>1181</code><code>    &lt;img src="/ct2/html/images/NIH_NLM_ABRV_BLK_4.png" style="width:5em; float:right;" alt=""/&gt;</code></p><p><code>1182</code><code>    &lt;p&gt;</code></p><p><code>1183</code><code>    &lt;p&gt;</code></p><p><code>1184</code><code>    &lt;em&gt;</code></p><p><code>1185</code><code>    To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.</code></p><p><code>1186</code><code>    &lt;/em&gt;</code></p><p><code>1187</code><code>    &lt;p&gt;</code></p><p><code>1188</code><code>    &lt;em&gt;</code></p><p><code>1189</code><code>    Please refer to this study by its ClinicalTrials.gov identifier (NCT number): &lt;strong&gt;NCT04065399&lt;/strong&gt;</code></p><p><code>1190</code><code>    &lt;/em&gt;</code></p><p><code>1191</code><code>  &lt;/div&gt;</code></p><p><code>1192</code><code>  &lt;br/&gt;</code></p><p><code>1193</code><code>          </code></p><p><code>1194</code><code>  &lt;!-- contacts --&gt;</code></p><p><code>1195</code><code>    &lt;div class="ct-header3" style="margin-top:2ex"&gt;Contacts&lt;/div&gt;</code></p><p><code>1196</code><code>  &lt;div class="tr-table_cover"&gt;</code></p><p><code>1197</code><code>    &lt;table class="ct-layout_table tr-indent2"&gt;</code></p><p><code>1198</code><code>      &lt;caption&gt;Layout table for location contacts&lt;/caption&gt;</code></p><p><code>1199</code><code>    &lt;thead&gt;</code></p><p><code>1200</code><code>    &lt;tr&gt;</code></p><p><code>1201</code><code>      &lt;th id="contactName" style="visibility:hidden"&gt;&lt;/th&gt;</code></p><p><code>1202</code><code>      &lt;th id="contactPhone" style="visibility:hidden"&gt;&lt;/th&gt;</code></p><p><code>1203</code><code>      &lt;th id="contactEmail" style="visibility:hidden"&gt;&lt;/th&gt;</code></p><p><code>1204</code><code>      &lt;th id="contactAddress" style="visibility:hidden"&gt;&lt;/th&gt;</code></p><p><code>1205</code><code>    &lt;/tr&gt;</code></p><p><code>1206</code><code>    &lt;/thead&gt;</code></p><p><code>1207</code><code>        &lt;tr&gt;</code></p><p><code>1208</code><code>      &lt;td headers="contactName"&gt;Contact: Syndax Pharmaceuticals&lt;/td&gt;</code></p><p><code>1209</code><code>            &lt;td headers="contactPhone"&gt;781-419-1400&lt;/td&gt;</code></p><p><code>1210</code><code>                  &lt;td headers="contactEmail"&gt;&lt;a href="mailto:clinicaltrials%40syndax.com?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;clinicaltrials@syndax.com&lt;/a&gt;&lt;/td&gt;</code></p><p><code>1211</code><code>                  &lt;td headers="contactAddress"&gt;&lt;/td&gt;</code></p><p><code>1212</code><code>          &lt;/tr&gt;</code></p><p><code>1213</code><code>      &lt;/table&gt;</code></p><p><code>1214</code><code>  &lt;/div&gt;</code></p><p><code>1215</code><code>  &lt;br/&gt;</code></p><p><code>1216</code><code>  </code></p><p><code>1217</code><code>  &lt;!-- locations --&gt;</code></p><p><code>1218</code><code>   &lt;a id="locn"&gt;&lt;/a&gt;</code></p><p><code>1219</code><code>  &lt;div class="ct-header3" style="margin-top:2ex;margin-bottom:2ex;"&gt;Locations&lt;/div&gt;</code></p><p><code>1220</code><code>          </code></p><p><code>1221</code><code>      &lt;script type="text/javascript" async src="/ct2/html/js/ExpandCollapseScript.js"&gt;&lt;/script&gt;</code></p><p><code>1222</code><code>    </code></p><p><code>1223</code><code>    &lt;span id="EXPAND_CONTROL-Locations" class="EXPAND tr-showAndHide"       onclick="toggleSectionAndControls('-Locations');document.getElementById('locn').scrollIntoView({behavior: 'smooth', block: 'start'});" </code></p><p><code>1224</code><code>      title="Show 31 study locations"&gt;</code></p><p><code>1225</code><code>      &lt;img src="/ct2/html/images/expand.png" alt="Show"&gt;</code></p><p><code>1226</code><code>      &lt;span style="padding-bottom:3px"&gt; Show 31 study locations&lt;/span&gt;</code></p><p><code>1227</code><code>    &lt;/span&gt;</code></p><p><code>1228</code><code>    &lt;span  id="COLLAPSE_CONTROL-Locations" class="COLLAPSE tr-showAndHide" style="display:none"      onclick="toggleSectionAndControls('-Locations');" </code></p><p><code>1229</code><code>      title="Hide 31 study locations"&gt;</code></p><p><code>1230</code><code>      &lt;img src="/ct2/html/images/collapse.png"  alt="Hide"&gt;</code></p><p><code>1231</code><code>      &lt;span style="padding-bottom:3px"&gt; Hide 31 study locations&lt;/span&gt;</code></p><p><code>1232</code><code>    &lt;/span&gt;</code></p><p><code>1233</code><code>     </code></p><p><code>1234</code><code>  &lt;div id="COLLAPSE-Locations" class="COLLAPSE" style="display:none"&gt;</code></p><p><code>1235</code><code>        &lt;div class="tr-table_cover"&gt;</code></p><p><code>1236</code><code>      &lt;table class="ct-layout_table tr-indent2"&gt;</code></p><p><code>1237</code><code>        &lt;caption&gt;Layout table for location information&lt;/caption&gt;</code></p><p><code>1238</code><code>        &lt;thead&gt;</code></p><p><code>1239</code><code>          &lt;tr&gt;</code></p><p><code>1240</code><code>            &lt;th id="locName"&gt;&lt;/th&gt;</code></p><p><code>1241</code><code>            &lt;th id="locStatus"&gt;&lt;/th&gt;</code></p><p><code>1242</code><code>          &lt;/tr&gt;</code></p><p><code>1243</code><code>        &lt;/thead&gt;</code></p><p><code>1244</code><code>        &lt;tbody&gt;</code></p><p><code>1245</code><code>                                    &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, California&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1246</code><code>                                      &lt;tr&gt;</code></p><p><code>1247</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;City of Hope Comprehensive Cancer Center&lt;/td&gt;</code></p><p><code>1248</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1249</code><code>                          &lt;/tr&gt;</code></p><p><code>1250</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Duarte, California, United States, 91010  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1251</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Manjyot Nanhwan &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;a href="mailto:mnanhwan%40coh.org?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;mnanhwan@coh.org&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1252</code><code>                                                            &lt;tr&gt;</code></p><p><code>1253</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Stanford Cancer Institute&lt;/td&gt;</code></p><p><code>1254</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1255</code><code>                          &lt;/tr&gt;</code></p><p><code>1256</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Palo Alto, California, United States, 94305  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1257</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Kyle Denzel Cobarrubias &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;a href="mailto:kcobarru%40stanford.edu?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;kcobarru@stanford.edu&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1258</code><code>                                                              &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Colorado&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1259</code><code>                                      &lt;tr&gt;</code></p><p><code>1260</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;University of Colorado&lt;/td&gt;</code></p><p><code>1261</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1262</code><code>                          &lt;/tr&gt;</code></p><p><code>1263</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Aurora, Colorado, United States, 80045  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1264</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Katelyn Anttila &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;a href="mailto:Katelyn.Anttila%40ucdenver.edu?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;Katelyn.Anttila@ucdenver.edu&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1265</code><code>                                                              &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Florida&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1266</code><code>                                      &lt;tr&gt;</code></p><p><code>1267</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Florida Cancer Specialists and Research Institute&lt;/td&gt;</code></p><p><code>1268</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1269</code><code>                          &lt;/tr&gt;</code></p><p><code>1270</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Sarasota, Florida, United States, 34232  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1271</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Terri Peterson, RN &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;a href="mailto:tpeterson%40flcancer.com?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;tpeterson@flcancer.com&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1272</code><code>                                                            &lt;tr&gt;</code></p><p><code>1273</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Moffitt Cancer Center&lt;/td&gt;</code></p><p><code>1274</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Completed&lt;/td&gt;</code></p><p><code>1275</code><code>                          &lt;/tr&gt;</code></p><p><code>1276</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Tampa, Florida, United States, 33162  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1277</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Georgia&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1278</code><code>                                      &lt;tr&gt;</code></p><p><code>1279</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Emory Winship Cancer Institute&lt;/td&gt;</code></p><p><code>1280</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1281</code><code>                          &lt;/tr&gt;</code></p><p><code>1282</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Atlanta, Georgia, United States, 30322  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1283</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Shannon Gleason, MLS, CCRC &amp;nbsp;&amp;nbsp; 404-778-4334 ext 10808 &amp;nbsp;&amp;nbsp; &lt;a href="mailto:shannon.gleason%40emory.edu?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;shannon.gleason@emory.edu&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1284</code><code>                                                            &lt;tr&gt;</code></p><p><code>1285</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Children's Healthcare of Atlanta&lt;/td&gt;</code></p><p><code>1286</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1287</code><code>                          &lt;/tr&gt;</code></p><p><code>1288</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Atlanta, Georgia, United States, 30329  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1289</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Aflac Cancer &amp;amp; Blood Disorders Center Referral &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;a href="mailto:aflacdevtreferral%40choa.org?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;aflacdevtreferral@choa.org&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1290</code><code>                                                              &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Illinois&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1291</code><code>                                      &lt;tr&gt;</code></p><p><code>1292</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;The University of Chicago Medical Center&lt;/td&gt;</code></p><p><code>1293</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1294</code><code>                          &lt;/tr&gt;</code></p><p><code>1295</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Chicago, Illinois, United States, 60637  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1296</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Howie Weiner, CCRP &amp;nbsp;&amp;nbsp; 773-702-2084 &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1297</code><code>                                                              &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Iowa&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1298</code><code>                                      &lt;tr&gt;</code></p><p><code>1299</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;University of Iowa hospital&lt;/td&gt;</code></p><p><code>1300</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1301</code><code>                          &lt;/tr&gt;</code></p><p><code>1302</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Iowa City, Iowa, United States, 52246  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1303</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Principal Investigator: David Dickens, MD &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1304</code><code>                                                              &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Massachusetts&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1305</code><code>                                      &lt;tr&gt;</code></p><p><code>1306</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Dana Farber Cancer Institute&lt;/td&gt;</code></p><p><code>1307</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1308</code><code>                          &lt;/tr&gt;</code></p><p><code>1309</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Boston, Massachusetts, United States, 02215  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1310</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Morgan Johnson &amp;nbsp;&amp;nbsp; 857-215-0238 &amp;nbsp;&amp;nbsp; &lt;a href="mailto:Morgan_Johnson%40DFCI.HARVARD.EDU?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;Morgan_Johnson@DFCI.HARVARD.EDU&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1311</code><code>                              &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Lindsay Rae &amp;nbsp;&amp;nbsp; 617-582-9169 &amp;nbsp;&amp;nbsp; &lt;a href="mailto:Lindsey_Rae%40DFCI.HARVARD.EDU?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;Lindsey_Rae@DFCI.HARVARD.EDU&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1312</code><code>                                                              &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Missouri&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1313</code><code>                                      &lt;tr&gt;</code></p><p><code>1314</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Washington University in St. Louis School of Medicine&lt;/td&gt;</code></p><p><code>1315</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1316</code><code>                          &lt;/tr&gt;</code></p><p><code>1317</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Saint Louis, Missouri, United States, 63110  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1318</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Hannah Hartman &amp;nbsp;&amp;nbsp; 314-273-8628 &amp;nbsp;&amp;nbsp; &lt;a href="mailto:hannahlhartman%40wustl.edu?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;hannahlhartman@wustl.edu&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1319</code><code>                              &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Madeline Stowe &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;a href="mailto:mstowe%40wustl.edu?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;mstowe@wustl.edu&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1320</code><code>                                                              &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, New Jersey&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1321</code><code>                                      &lt;tr&gt;</code></p><p><code>1322</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Hackensack University Medical Center&lt;/td&gt;</code></p><p><code>1323</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1324</code><code>                          &lt;/tr&gt;</code></p><p><code>1325</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Hackensack, New Jersey, United States, 07601  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1326</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Principal Investigator: Jing Chen, MD &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1327</code><code>                                                              &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, New York&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1328</code><code>                                      &lt;tr&gt;</code></p><p><code>1329</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Memorial Sloan Kettering Cancer Center&lt;/td&gt;</code></p><p><code>1330</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1331</code><code>                          &lt;/tr&gt;</code></p><p><code>1332</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;New York, New York, United States, 10065  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1333</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Kait Tkachuk &amp;nbsp;&amp;nbsp; 646-608-2783 &amp;nbsp;&amp;nbsp; &lt;a href="mailto:tkachukk%40mskcc.org?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;tkachukk@mskcc.org&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1334</code><code>                                                            &lt;tr&gt;</code></p><p><code>1335</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Montefiore Medical Center&lt;/td&gt;</code></p><p><code>1336</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1337</code><code>                          &lt;/tr&gt;</code></p><p><code>1338</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;New York, New York, United States, 10467  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1339</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Karen Fehn &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;a href="mailto:KFEHN%40montefiore.org?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;KFEHN@montefiore.org&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1340</code><code>                              &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Joel Victor &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;a href="mailto:jovictor%40montefiore.org?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;jovictor@montefiore.org&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1341</code><code>                                                              &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Ohio&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1342</code><code>                                      &lt;tr&gt;</code></p><p><code>1343</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;University of Cincinnati&lt;/td&gt;</code></p><p><code>1344</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1345</code><code>                          &lt;/tr&gt;</code></p><p><code>1346</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Cincinnati, Ohio, United States, 45267  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1347</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Nadia Osman &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;a href="mailto:osmann%40ucmail.uc.edu?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;osmann@ucmail.uc.edu&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1348</code><code>                                                            &lt;tr&gt;</code></p><p><code>1349</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Ohio State University&lt;/td&gt;</code></p><p><code>1350</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1351</code><code>                          &lt;/tr&gt;</code></p><p><code>1352</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Columbus, Ohio, United States, 43201  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1353</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Molly Brandenburg &amp;nbsp;&amp;nbsp; 614-366-7951 &amp;nbsp;&amp;nbsp; &lt;a href="mailto:molly.brandenburg%40osumc.edu?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;molly.brandenburg@osumc.edu&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1354</code><code>                                                              &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Oregon&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1355</code><code>                                      &lt;tr&gt;</code></p><p><code>1356</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Oregon Health &amp;amp; Science University&lt;/td&gt;</code></p><p><code>1357</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1358</code><code>                          &lt;/tr&gt;</code></p><p><code>1359</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Portland, Oregon, United States, 97239  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1360</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: OHSU Knight Cancer Institute Clinical Trials &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;a href="mailto:trials%40ohsu.edu?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;trials@ohsu.edu&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1361</code><code>                              &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Principal Investigator: Ronan Swords, MD &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1362</code><code>                                                              &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Pennsylvania&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1363</code><code>                                      &lt;tr&gt;</code></p><p><code>1364</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;University of Pennsylvania&lt;/td&gt;</code></p><p><code>1365</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1366</code><code>                          &lt;/tr&gt;</code></p><p><code>1367</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Philadelphia, Pennsylvania, United States, 19104  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1368</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Robin E Blauser, BSN RN &amp;nbsp;&amp;nbsp; 215-662-2870 &amp;nbsp;&amp;nbsp; &lt;a href="mailto:Robin.Blauser%40pennmedicine.upenn.edu?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;Robin.Blauser@pennmedicine.upenn.edu&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1369</code><code>                                                              &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Texas&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1370</code><code>                                      &lt;tr&gt;</code></p><p><code>1371</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;The University of Texas MD Anderson Cancer Center&lt;/td&gt;</code></p><p><code>1372</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1373</code><code>                          &lt;/tr&gt;</code></p><p><code>1374</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Houston, Texas, United States, 77030  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1375</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Ghayas Issa, MD &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;a href="mailto:gcissa%40mdanderson.org?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;gcissa@mdanderson.org&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1376</code><code>                                                              &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Utah&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1377</code><code>                                      &lt;tr&gt;</code></p><p><code>1378</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Huntsman Cancer Institute at the University of Utah&lt;/td&gt;</code></p><p><code>1379</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1380</code><code>                          &lt;/tr&gt;</code></p><p><code>1381</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Salt Lake City, Utah, United States, 84112  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1382</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Jessica Hammond &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;a href="mailto:Jessica.Hammond%40hci.utah.edu?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;Jessica.Hammond@hci.utah.edu&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1383</code><code>                              &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Catherine Cromar &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;a href="mailto:Catherine.Cromar%40hci.utah.edu?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;Catherine.Cromar@hci.utah.edu&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1384</code><code>                                                              &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;Australia, Victoria&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1385</code><code>                                      &lt;tr&gt;</code></p><p><code>1386</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Peter MacCallum Cancer Centre (PMCC)&lt;/td&gt;</code></p><p><code>1387</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1388</code><code>                          &lt;/tr&gt;</code></p><p><code>1389</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Melbourne, Victoria, Australia, 3000  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1390</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Farha Inam &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;a href="mailto:PCCTU.HaemA%40petermac.org?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;PCCTU.HaemA@petermac.org&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1391</code><code>                                                              &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;Australia&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1392</code><code>                                      &lt;tr&gt;</code></p><p><code>1393</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Alfred Hospital&lt;/td&gt;</code></p><p><code>1394</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1395</code><code>                          &lt;/tr&gt;</code></p><p><code>1396</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Melbourne, Australia, 3004  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1397</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Principal Investigator: Shaun Fleming, MD &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1398</code><code>                                                            &lt;tr&gt;</code></p><p><code>1399</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Sir Charles Gairdner Hospital&lt;/td&gt;</code></p><p><code>1400</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1401</code><code>                          &lt;/tr&gt;</code></p><p><code>1402</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Nedlands, Australia, 6009  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1403</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Principal Investigator: Carolyn Grove, MD &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1404</code><code>                                                            &lt;tr&gt;</code></p><p><code>1405</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Royal North Shore Hospital&lt;/td&gt;</code></p><p><code>1406</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1407</code><code>                          &lt;/tr&gt;</code></p><p><code>1408</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Saint Leonards, Australia, 2065  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1409</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Principal Investigator: Matthew Greenwood, MD &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1410</code><code>                                                              &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;Canada&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1411</code><code>                                      &lt;tr&gt;</code></p><p><code>1412</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Princess Margaret Cancer Centre&lt;/td&gt;</code></p><p><code>1413</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1414</code><code>                          &lt;/tr&gt;</code></p><p><code>1415</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Toronto, Canada, M5G 2M9  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1416</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Principal Investigator: Andre Schuh &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1417</code><code>                                                            &lt;tr&gt;</code></p><p><code>1418</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;University Health Network&lt;/td&gt;</code></p><p><code>1419</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1420</code><code>                          &lt;/tr&gt;</code></p><p><code>1421</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Toronto, Canada, M5G 2M9  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1422</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Principal Investigator: Andre Schuh, MD &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1423</code><code>                                                            &lt;tr&gt;</code></p><p><code>1424</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;The Hospital for Sick Children&lt;/td&gt;</code></p><p><code>1425</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1426</code><code>                          &lt;/tr&gt;</code></p><p><code>1427</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Toronto, Canada  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1428</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Aiman Siddiqi &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;a href="mailto:aiman.siddiqi%40sickkids.ca?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;aiman.siddiqi@sickkids.ca&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1429</code><code>                                                              &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;France&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1430</code><code>                                      &lt;tr&gt;</code></p><p><code>1431</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Centre Hospitalier Lyon Sud&lt;/td&gt;</code></p><p><code>1432</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1433</code><code>                          &lt;/tr&gt;</code></p><p><code>1434</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Pierre-Benite, France, 69495  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1435</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Alexandre Deloire &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;a href="mailto:Alexandre.deloire%40chu-lyon.fr?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;Alexandre.deloire@chu-lyon.fr&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1436</code><code>                                                              &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;Israel&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1437</code><code>                                      &lt;tr&gt;</code></p><p><code>1438</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Hadassah Medical Center- Ein Kerem&lt;/td&gt;</code></p><p><code>1439</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1440</code><code>                          &lt;/tr&gt;</code></p><p><code>1441</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Jerusalem, Israel  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1442</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Principal Investigator: Boaz Nachmias &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1443</code><code>                                                              &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;Netherlands&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1444</code><code>                                      &lt;tr&gt;</code></p><p><code>1445</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Princess Maxima Center for Pediatric Oncology&lt;/td&gt;</code></p><p><code>1446</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1447</code><code>                          &lt;/tr&gt;</code></p><p><code>1448</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Utrecht, Netherlands, 3584 CS  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1449</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Contact: Secretary Trial and Data Centrum &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;a href="mailto:tdcsecretary%40prinsesmaximacentrum.nl?subject=NCT04065399, SNDX-5613-0700, A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation"&gt;tdcsecretary@prinsesmaximacentrum.nl&lt;/a&gt; &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1450</code><code>                                                              &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;Spain&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1451</code><code>                                      &lt;tr&gt;</code></p><p><code>1452</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Hospital Universitari I Polit&amp;#232;cnic La Fe Avinguda Fernando Abril Martorell&lt;/td&gt;</code></p><p><code>1453</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1454</code><code>                          &lt;/tr&gt;</code></p><p><code>1455</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Valencia, Spain, 46026  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1456</code><code>                                                      &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em"&gt;Principal Investigator: Pau Montesinos Fernandez &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp;  &amp;nbsp;&amp;nbsp; &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1457</code><code>                                            &lt;/tbody&gt;</code></p><p><code>1458</code><code>      &lt;/table&gt;</code></p><p><code>1459</code><code>    &lt;/div&gt;</code></p><p><code>1460</code><code>  &lt;/div&gt;   </code></p><p><code>1461</code><code>  </code></p><p><code>1462</code><code>  &lt;!-- sponsors --&gt;</code></p><p><code>1463</code><code>      &lt;div class="ct-header3" style="margin-top:2ex"&gt;Sponsors and Collaborators&lt;/div&gt;</code></p><p><code>1464</code><code>              &lt;div class="tr-indent2" style="margin-top:1ex"&gt;Syndax Pharmaceuticals&lt;/div&gt;</code></p><p><code>1465</code><code>        </code></p><p><code>1466</code><code>  &lt;!-- overall officials --&gt;</code></p><p><code>1467</code><code>    &lt;div class="ct-header3" style="margin-top:2ex"&gt;Investigators&lt;/div&gt;</code></p><p><code>1468</code><code>  &lt;div class="tr-table_cover"&gt;</code></p><p><code>1469</code><code>  &lt;table class="ct-layout_table tr-indent2"&gt;</code></p><p><code>1470</code><code>    &lt;caption&gt;Layout table for investigator information&lt;/caption&gt;</code></p><p><code>1471</code><code>    &lt;thead&gt;</code></p><p><code>1472</code><code>    &lt;tr&gt;</code></p><p><code>1473</code><code>      &lt;th id="role" style="visibility:hidden"&gt;&lt;/th&gt;</code></p><p><code>1474</code><code>      &lt;th id="name" style="visibility:hidden"&gt;&lt;/th&gt;</code></p><p><code>1475</code><code>      &lt;th id="affiliation" style="visibility:hidden"&gt;&lt;/th&gt;</code></p><p><code>1476</code><code>      &lt;th id="address" style="visibility:hidden"&gt;&lt;/th&gt;</code></p><p><code>1477</code><code>    &lt;/tr&gt;</code></p><p><code>1478</code><code>    &lt;/thead&gt;</code></p><p><code>1479</code><code>        &lt;tr&gt;</code></p><p><code>1480</code><code>      &lt;td headers="role"&gt;Study Director:&lt;/td&gt;</code></p><p><code>1481</code><code>      &lt;td headers="name"&gt;Nicole McNeer, M.D.&lt;/td&gt;</code></p><p><code>1482</code><code>            &lt;td headers="affiliation"&gt;Syndax Pharmaceuticals&lt;/td&gt;</code></p><p><code>1483</code><code>            &lt;td headers="address"&gt;&lt;/td&gt;</code></p><p><code>1484</code><code>    &lt;/tr&gt;</code></p><p><code>1485</code><code>      &lt;/table&gt;</code></p><p><code>1486</code><code>  &lt;/div&gt;</code></p><p><code>1487</code><code>  </code></p><p><code>1488</code><code>          </code></p><p><code>1489</code><code>&lt;/div&gt;</code></p><p><code>1490</code><code>&lt;/div&gt;</code></p><p><code>1491</code><code>						</code></p><p><code>1492</code><code>&lt;!-- more_info_section --&gt;</code></p><p><code>1493</code><code>          </code></p><p><code>1494</code><code>&lt;!-- Large docs section --&gt;</code></p><p><code>1495</code><code>          </code></p><p><code>1496</code><code>    </code></p><p><code>1497</code><code>          </code></p><p><code>1498</code><code>&lt;!-- More info section --&gt;</code></p><p><code>1499</code><code>  &lt;div class="tr-indent1" style="margin-top:3ex; border:1px solid white"&gt;</code></p><p><code>1500</code><code>  &lt;div class="tr-subsection"&gt;</code></p><p><code>1501</code><code>  	&lt;div class="ct-header2"&gt;&lt;a id="moreinfo"&gt;&lt;/a&gt;More Information&lt;/div&gt;</code></p><p><code>1502</code><code>  	&lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>1503</code><code>  	&lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>1504</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>1505</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>1506</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>1507</code><code>&lt;/button&gt;</code></p><p><code>1508</code><code>          </code></p><p><code>1509</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>1510</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>1511</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>1512</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>1513</code><code>          </code></p><p><code>1514</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>1515</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>1516</code><code>    </code></p><p><code>1517</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>1518</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>1519</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>1520</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>1521</code><code>  &lt;/div&gt;</code></p><p><code>1522</code><code>&lt;/div&gt;</code></p><p><code>1523</code><code>  &lt;/div&gt;</code></p><p><code>1524</code><code>  </code></p><p><code>1525</code><code>  &lt;div class="tr-indent2" style="margin-top:1em;"&gt;</code></p><p><code>1526</code><code>          </code></p><p><code>1527</code><code>          </code></p><p><code>1528</code><code>    &lt;!-- Additional Information --&gt;</code></p><p><code>1529</code><code>        &lt;span class="ct-header3"&gt;Additional Information:&lt;/span&gt;</code></p><p><code>1530</code><code>    &lt;div class="tr-indent2"&gt;  </code></p><p><code>1531</code><code>      &lt;!-- See Also Links --&gt;</code></p><p><code>1532</code><code>                        &lt;div style="margin-top:2ex;"&gt;</code></p><p><code>1533</code><code>	          	            &lt;a class="tr-study-link" href="/ct2/bye/SQoPWwoRrXS9-i-wudNGWi1yzXNgZdD9kwUPeBcazwS9Fg4jLK4BmR4nFXCtLK4jSXCR/R8NHvB1Pz6Y3ydN6Z" title="Related Info" onclick="openNewWindow('/ct2/bye/SQoPWwoRrXS9-i-wudNGWi1yzXNgZdD9kwUPeBcazwS9Fg4jLK4BmR4nFXCtLK4jSXCR/R8NHvB1Pz6Y3ydN6Z'); return false"&gt;Related Info&lt;/a&gt;&amp;nbsp;</code></p><p><code>1534</code><code>	            &lt;img src="/ct2/html/images/frame/exit.bmp" alt="This link exits the ClinicalTrials.gov site"/&gt;</code></p><p><code>1535</code><code>	          	      &lt;/div&gt;</code></p><p><code>1536</code><code>                  &lt;div style="margin-top:2ex;"&gt;</code></p><p><code>1537</code><code>	          	            &lt;a class="tr-study-link" href="/ct2/bye/SQoPWwoRrXS9-i-wudNGWi1yzXNgZdD9kwUPeBcazwS9Fg4jLK4BmR4nFXCtLgF8LXC5/R8NHvB1Pz6Y3ydN6Z" title="Related Info" onclick="openNewWindow('/ct2/bye/SQoPWwoRrXS9-i-wudNGWi1yzXNgZdD9kwUPeBcazwS9Fg4jLK4BmR4nFXCtLgF8LXC5/R8NHvB1Pz6Y3ydN6Z'); return false"&gt;Related Info&lt;/a&gt;&amp;nbsp;</code></p><p><code>1538</code><code>	            &lt;img src="/ct2/html/images/frame/exit.bmp" alt="This link exits the ClinicalTrials.gov site"/&gt;</code></p><p><code>1539</code><code>	          	      &lt;/div&gt;</code></p><p><code>1540</code><code>                  &lt;/div&gt;</code></p><p><code>1541</code><code>    &lt;br/&gt;</code></p><p><code>1542</code><code>    </code></p><p><code>1543</code><code>          </code></p><p><code>1544</code><code>    &lt;!-- Available Study Data/Document --&gt;</code></p><p><code>1545</code><code>    </code></p><p><code>1546</code><code>          </code></p><p><code>1547</code><code>  &lt;!-- References --&gt;</code></p><p><code>1548</code><code>    </code></p><p><code>1549</code><code>    </code></p><p><code>1550</code><code>  &lt;!-- Derived References --&gt;</code></p><p><code>1551</code><code>        &lt;span class="ct-header3"&gt;Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):&lt;/span&gt;</code></p><p><code>1552</code><code>      &lt;div class="tr-indent2"&gt;</code></p><p><code>1553</code><code>                &lt;div style="margin-top:2ex"&gt;</code></p><p><code>1554</code><code>                    &lt;a href="/ct2/bye/rQoPWwoRrXS9-i-wudNgpQDxudhWudNzlXNiZip9Ei7ym67VZRFVSg0wEgF5A6h9Ei4L3BUgWwNG0it." title="Sasca D, Guezguez B, Kuhn MWM. Next generation epigenetic modulators to target myeloid neoplasms. Curr Opin Hematol. 2021 Sep 1;28(5):356-363. doi: 10.1097/MOH.0000000000000673." onclick="openNewWindow('/ct2/bye/rQoPWwoRrXS9-i-wudNgpQDxudhWudNzlXNiZip9Ei7ym67VZRFVSg0wEgF5A6h9Ei4L3BUgWwNG0it.'); return false"&gt;Sasca D, Guezguez B, Kuhn MWM. Next generation epigenetic modulators to target myeloid neoplasms. Curr Opin Hematol. 2021 Sep 1;28(5):356-363. doi: 10.1097/MOH.0000000000000673.&lt;/a&gt;</code></p><p><code>1555</code><code>                            &lt;/div&gt;</code></p><p><code>1556</code><code>                &lt;div style="margin-top:2ex"&gt;</code></p><p><code>1557</code><code>                    &lt;a href="/ct2/bye/rQoPWwoRrXS9-i-wudNgpQDxudhWudNzlXNiZip9Ei7ym67VZRFR-g4j-RC8A6h9Ei4L3BUgWwNG0it." title="Jimenez JA, Apfelbaum AA, Hawkins AG, Svoboda LK, Kumar A, Ruiz RO, Garcia AX, Haarer E, Nwosu ZC, Bradin J, Purohit T, Chen D, Cierpicki T, Grembecka J, Lyssiotis CA, Lawlor ER. EWS-FLI1 and Menin Converge to Regulate ATF4 Activity in Ewing Sarcoma. Mol Cancer Res. 2021 Jul;19(7):1182-1195. doi: 10.1158/1541-7786.MCR-20-0679. Epub 2021 Mar 19." onclick="openNewWindow('/ct2/bye/rQoPWwoRrXS9-i-wudNgpQDxudhWudNzlXNiZip9Ei7ym67VZRFR-g4j-RC8A6h9Ei4L3BUgWwNG0it.'); return false"&gt;Jimenez JA, Apfelbaum AA, Hawkins AG, Svoboda LK, Kumar A, Ruiz RO, Garcia AX, Haarer E, Nwosu ZC, Bradin J, Purohit T, Chen D, Cierpicki T, Grembecka J, Lyssiotis CA, Lawlor ER. EWS-FLI1 and Menin Converge to Regulate ATF4 Activity in Ewing Sarcoma. Mol Cancer Res. 2021 Jul;19(7):1182-1195. doi: 10.1158/1541-7786.MCR-20-0679. Epub 2021 Mar 19.&lt;/a&gt;</code></p><p><code>1558</code><code>                            &lt;/div&gt;</code></p><p><code>1559</code><code>              &lt;/div&gt;</code></p><p><code>1560</code><code>      &lt;br/&gt;</code></p><p><code>1561</code><code>    </code></p><p><code>1562</code><code>   </code></p><p><code>1563</code><code>  &lt;table class="ct-layout_table tr-tableStyle tr-moreInfo" style="margin-top:1ex;"&gt;</code></p><p><code>1564</code><code>    &lt;caption&gt;Layout table for additonal information&lt;/caption&gt;</code></p><p><code>1565</code><code>    &lt;thead&gt;</code></p><p><code>1566</code><code>    &lt;tr&gt;</code></p><p><code>1567</code><code>      &lt;th id="colTitle1"&gt;&lt;/th&gt;</code></p><p><code>1568</code><code>      &lt;th id="colData1"&gt;&lt;/th&gt;</code></p><p><code>1569</code><code>    &lt;/tr&gt;</code></p><p><code>1570</code><code>    &lt;/thead&gt;</code></p><p><code>1571</code><code>    &lt;tbody&gt;</code></p><p><code>1572</code><code>        &lt;tr&gt;</code></p><p><code>1573</code><code>      &lt;td headers="colTitle1" class="ct-nowrap"&gt;Responsible Party:&lt;/td&gt;</code></p><p><code>1574</code><code>      &lt;td headers="colData1" style="padding-left:1em"&gt;Syndax Pharmaceuticals&lt;/td&gt;</code></p><p><code>1575</code><code>    &lt;/tr&gt;</code></p><p><code>1576</code><code>        &lt;tr&gt;</code></p><p><code>1577</code><code>      &lt;td headers="colTitle1" class="ct-nowrap"&gt;ClinicalTrials.gov Identifier:&lt;/td&gt;</code></p><p><code>1578</code><code>      &lt;td headers="colData1" style="padding-left:1em"&gt;</code></p><p><code>1579</code><code>        &lt;a class="tr-study-link" title="Current version of study NCT04065399 on ClinicalTrials.gov" href="https://classic.clinicaltrials.gov/show/NCT04065399"&gt;NCT04065399&lt;/a&gt; &amp;nbsp; &amp;nbsp;</code></p><p><code>1580</code><code>        </code></p><p><code>1581</code><code>  &lt;script type="text/javascript"&gt;</code></p><p><code>1582</code><code>    &lt;!--</code></p><p><code>1583</code><code>    // Scramble access to archive site -</code></p><p><code>1584</code><code>    // don't want crawlers directing users to outdated versions of the study</code></p><p><code>1585</code><code>    // this should be opaque to crawlers that don't execute javascript</code></p><p><code>1586</code><code>    var yyy=new Array(</code></p><p><code>1587</code><code>      ['&lt;','a clas','s="tr-study','-link c', 't-now','rap" t','itle="Hist','orical vers','ions of '],</code></p><p><code>1588</code><code>      ['study ','NCT04065399',' on Clin','icalTrials.','go'],</code></p><p><code>1589</code><code>      ['v Ar','chive',' Sit','e" ','onc','lick="','openN','ewWin', 'dow(','\'/ct2/', 'history/'],</code></p><p><code>1590</code><code>      ['NCT04065399','\'); return', ' false;" '],</code></p><p><code>1591</code><code>      ['href','="/ct2/','history/','NCT04065399"','&gt;'],</code></p><p><code>1592</code><code>      ['Histo','ry of C','hange','s&lt;','/','a&gt;']);</code></p><p><code>1593</code><code>    var i=0;</code></p><p><code>1594</code><code>    var j=0;</code></p><p><code>1595</code><code>    var xxx='';</code></p><p><code>1596</code><code>    for (i=0; i&lt;yyy.length; i++)</code></p><p><code>1597</code><code>      for (j=0; j&lt;yyy[i].length; j++)</code></p><p><code>1598</code><code>        xxx+=yyy[i][j];</code></p><p><code>1599</code><code>    document.write(xxx)</code></p><p><code>1600</code><code>    --&gt;</code></p><p><code>1601</code><code>  &lt;/script&gt;</code></p><p><code>1602</code><code>          </code></p><p><code>1603</code><code>      &lt;/td&gt;</code></p><p><code>1604</code><code>    &lt;/tr&gt;</code></p><p><code>1605</code><code>            &lt;tr&gt;</code></p><p><code>1606</code><code>      &lt;td headers="colTitle1" class="ct-nowrap"&gt;Other Study ID Numbers:&lt;/td&gt;</code></p><p><code>1607</code><code>      &lt;td headers="colData1" style="padding-left:1em"&gt;</code></p><p><code>1608</code><code>                                    SNDX-5613-0700 &lt;br/&gt;</code></p><p><code>1609</code><code>                                                2020-004104-34 ( EudraCT Number )&lt;br/&gt;</code></p><p><code>1610</code><code>                            &lt;/td&gt;</code></p><p><code>1611</code><code>    &lt;/tr&gt;</code></p><p><code>1612</code><code>            &lt;tr&gt;</code></p><p><code>1613</code><code>      &lt;td headers="colTitle1" class="ct-nowrap"&gt;First Posted:&lt;/td&gt;</code></p><p><code>1614</code><code>      &lt;td headers="colData1" style="padding-left:1em"&gt;August 22, 2019</code></p><p><code>1615</code><code>          &amp;nbsp;&amp;nbsp;</code></p><p><code>1616</code><code>          &lt;a class="tr-study-link ct-nowrap" href="/ct2/keydates/NCT04065399"</code></p><p><code>1617</code><code>                title="View key record dates for NCT04065399"</code></p><p><code>1618</code><code>                onclick="openNewWindow('/ct2/keydates/NCT04065399'); return false;"&gt;Key Record Dates&lt;/a&gt;</code></p><p><code>1619</code><code>      &lt;/td&gt;</code></p><p><code>1620</code><code>    &lt;/tr&gt;</code></p><p><code>1621</code><code>            &lt;tr&gt;</code></p><p><code>1622</code><code>      &lt;td headers="colTitle1" class="ct-nowrap"&gt;Last Update Posted:&lt;/td&gt;</code></p><p><code>1623</code><code>      &lt;td headers="colData1" style="padding-left:1em"&gt;August 21, 2023</code></p><p><code>1624</code><code>      &lt;/td&gt;</code></p><p><code>1625</code><code>    &lt;/tr&gt;</code></p><p><code>1626</code><code>        &lt;tr&gt;</code></p><p><code>1627</code><code>      &lt;td headers="colTitle1" class="ct-nowrap"&gt;Last Verified:&lt;/td&gt;</code></p><p><code>1628</code><code>      &lt;td headers="colData1" style="padding-left:1em"&gt;August 2023</code></p><p><code>1629</code><code>      &lt;/td&gt;</code></p><p><code>1630</code><code>    &lt;/tr&gt;</code></p><p><code>1631</code><code>           </code></p><p><code>1632</code><code>    &lt;!-- Plan to Share Data --&gt;</code></p><p><code>1633</code><code>        &lt;/tbody&gt;</code></p><p><code>1634</code><code>  &lt;/table&gt;</code></p><p><code>1635</code><code>          </code></p><p><code>1636</code><code>    &lt;br/&gt;</code></p><p><code>1637</code><code>  &lt;table class="ct-layout_table tr-tableStyle tr-moreInfo" style="margin-top:1ex"&gt;</code></p><p><code>1638</code><code>    &lt;caption&gt;Layout table for additional information&lt;/caption&gt;</code></p><p><code>1639</code><code>    &lt;thead&gt;</code></p><p><code>1640</code><code>    &lt;tr&gt;</code></p><p><code>1641</code><code>      &lt;th id="colTitle2"&gt;&lt;/th&gt;</code></p><p><code>1642</code><code>      &lt;th id="colData2"&gt;&lt;/th&gt;</code></p><p><code>1643</code><code>    &lt;/tr&gt;</code></p><p><code>1644</code><code>    &lt;/thead&gt;</code></p><p><code>1645</code><code>    &lt;tbody&gt;       </code></p><p><code>1646</code><code>        &lt;tr&gt;</code></p><p><code>1647</code><code>      &lt;td headers="colTitle2" class="ct-nowrap"&gt;Studies a U.S. FDA-regulated Drug Product:&lt;/td&gt;</code></p><p><code>1648</code><code>      &lt;td headers="colData2" style="padding-left:1em"&gt;Yes&lt;/td&gt;</code></p><p><code>1649</code><code>    &lt;/tr&gt;</code></p><p><code>1650</code><code>            &lt;tr&gt;</code></p><p><code>1651</code><code>      &lt;td headers="colTitle2" class="ct-nowrap"&gt;Studies a U.S. FDA-regulated Device Product:&lt;/td&gt;</code></p><p><code>1652</code><code>      &lt;td headers="colData2" style="padding-left:1em"&gt;No&lt;/td&gt;</code></p><p><code>1653</code><code>    &lt;/tr&gt;</code></p><p><code>1654</code><code>                    &lt;/tbody&gt;</code></p><p><code>1655</code><code>  &lt;/table&gt;</code></p><p><code>1656</code><code>  </code></p><p><code>1657</code><code>  </code></p><p><code>1658</code><code>    &lt;!-- keywords --&gt;</code></p><p><code>1659</code><code>        	</code></p><p><code>1660</code><code>    	    	  	&lt;div class="tr-tableLabel"&gt;Keywords provided by Syndax Pharmaceuticals:&lt;/div&gt;</code></p><p><code>1661</code><code>    	    	&lt;div class="tr-indent3"&gt;</code></p><p><code>1662</code><code>          &lt;table class="ct-layout_table tr-moreInfo" style="width:100%;"&gt;</code></p><p><code>1663</code><code>    	      &lt;thead&gt;</code></p><p><code>1664</code><code>    	      &lt;tr&gt;</code></p><p><code>1665</code><code>    	        &lt;th id="keywordCol1" style="width:50%;"&gt;&lt;/th&gt;</code></p><p><code>1666</code><code>    	        &lt;th id="keywordCol2" style="width:50%;"&gt;&lt;/th&gt;</code></p><p><code>1667</code><code>    	      &lt;/tr&gt;</code></p><p><code>1668</code><code>    	      &lt;/thead&gt;</code></p><p><code>1669</code><code>    	      &lt;tr&gt;</code></p><p><code>1670</code><code>    	        &lt;td headers="keywordCol1" style="padding-left:1em;"&gt;</code></p><p><code>1671</code><code>    	              	          AML&lt;br/&gt;</code></p><p><code>1672</code><code>    	              	          ALL&lt;br/&gt;</code></p><p><code>1673</code><code>    	              	          MPAL&lt;br/&gt;</code></p><p><code>1674</code><code>    	              	          MLAL&lt;br/&gt;</code></p><p><code>1675</code><code>    	              	          ALAL&lt;br/&gt;</code></p><p><code>1676</code><code>    	              	          relapsed leukemia&lt;br/&gt;</code></p><p><code>1677</code><code>    	              	        &lt;/td&gt;</code></p><p><code>1678</code><code>    	            	        &lt;td headers="keywordCol2" style="padding-left:1em;"&gt;</code></p><p><code>1679</code><code>    	              	          refractory leukemia&lt;br/&gt;</code></p><p><code>1680</code><code>    	              	          acute leukemia&lt;br/&gt;</code></p><p><code>1681</code><code>    	              	          MLLr&lt;br/&gt;</code></p><p><code>1682</code><code>    	              	          KMT2A&lt;br/&gt;</code></p><p><code>1683</code><code>    	              	          NPM1&lt;br/&gt;</code></p><p><code>1684</code><code>    	              	        &lt;/td&gt;</code></p><p><code>1685</code><code>    	            	      &lt;/tr&gt;</code></p><p><code>1686</code><code>    	    &lt;/table&gt;</code></p><p><code>1687</code><code>    	&lt;/div&gt;</code></p><p><code>1688</code><code>    </code></p><p><code>1689</code><code>    &lt;!-- mesh terms --&gt;</code></p><p><code>1690</code><code>          &lt;div class="tr-tableLabel"&gt;Additional relevant MeSH terms:&lt;/div&gt;</code></p><p><code>1691</code><code>      &lt;div class="tr-indent3"&gt;</code></p><p><code>1692</code><code>        &lt;table class="ct-layout_table tr-meshTerms" style="width:100%;"&gt;</code></p><p><code>1693</code><code>          &lt;caption&gt;Layout table for MeSH terms&lt;/caption&gt;</code></p><p><code>1694</code><code>          &lt;thead&gt;</code></p><p><code>1695</code><code>          &lt;tr&gt;</code></p><p><code>1696</code><code>            &lt;th id="meshTermCol1" style="width:50%;"&gt;&lt;/th&gt;</code></p><p><code>1697</code><code>            &lt;th id="meshTermCol2"&gt;&lt;/th&gt;</code></p><p><code>1698</code><code>          &lt;/tr&gt;</code></p><p><code>1699</code><code>          &lt;/thead&gt;</code></p><p><code>1700</code><code>          &lt;tr&gt;</code></p><p><code>1701</code><code>            &lt;td headers="meshTermCol1" style="padding-left:1em;"&gt;</code></p><p><code>1702</code><code>                            Leukemia&lt;br/&gt;</code></p><p><code>1703</code><code>                            Precursor Cell Lymphoblastic Leukemia-Lymphoma&lt;br/&gt;</code></p><p><code>1704</code><code>                            Leukemia, Biphenotypic, Acute&lt;br/&gt;</code></p><p><code>1705</code><code>                            Acute Disease&lt;br/&gt;</code></p><p><code>1706</code><code>                            Neoplasms by Histologic Type&lt;br/&gt;</code></p><p><code>1707</code><code>                            Neoplasms&lt;br/&gt;</code></p><p><code>1708</code><code>                            Leukemia, Lymphoid&lt;br/&gt;</code></p><p><code>1709</code><code>                            Lymphoproliferative Disorders&lt;br/&gt;</code></p><p><code>1710</code><code>                            Lymphatic Diseases&lt;br/&gt;</code></p><p><code>1711</code><code>                            Immunoproliferative Disorders&lt;br/&gt;</code></p><p><code>1712</code><code>                            Immune System Diseases&lt;br/&gt;</code></p><p><code>1713</code><code>                          &lt;/td&gt;</code></p><p><code>1714</code><code>                        &lt;td headers="meshTermCol1" style="padding-left:1em;"&gt;</code></p><p><code>1715</code><code>                            Disease Attributes&lt;br/&gt;</code></p><p><code>1716</code><code>                            Pathologic Processes&lt;br/&gt;</code></p><p><code>1717</code><code>                            Cobicistat&lt;br/&gt;</code></p><p><code>1718</code><code>                            Anti-HIV Agents&lt;br/&gt;</code></p><p><code>1719</code><code>                            Anti-Retroviral Agents&lt;br/&gt;</code></p><p><code>1720</code><code>                            Antiviral Agents&lt;br/&gt;</code></p><p><code>1721</code><code>                            Anti-Infective Agents&lt;br/&gt;</code></p><p><code>1722</code><code>                            Cytochrome P-450 CYP3A Inhibitors&lt;br/&gt;</code></p><p><code>1723</code><code>                            Cytochrome P-450 Enzyme Inhibitors&lt;br/&gt;</code></p><p><code>1724</code><code>                            Enzyme Inhibitors&lt;br/&gt;</code></p><p><code>1725</code><code>                            Molecular Mechanisms of Pharmacological Action&lt;br/&gt;</code></p><p><code>1726</code><code>                          &lt;/td&gt;</code></p><p><code>1727</code><code>                      &lt;/tr&gt;</code></p><p><code>1728</code><code>        &lt;/table&gt;</code></p><p><code>1729</code><code>      &lt;/div&gt;</code></p><p><code>1730</code><code>    </code></p><p><code>1731</code><code>  &lt;br/&gt;</code></p><p><code>1732</code><code>          </code></p><p><code>1733</code><code>  &lt;!--</code></p><p><code>1734</code><code>        &lt;span class="ct-body3"&gt;ClinicalTrials.gov processed this record on September 26, 2023&lt;/span&gt;&lt;br/&gt;</code></p><p><code>1735</code><code>      --&gt;</code></p><p><code>1736</code><code>    &lt;br/&gt;  </code></p><p><code>1737</code><code>  &lt;/div&gt;</code></p><p><code>1738</code><code>   &lt;/div&gt;</code></p><p><code>1739</code><code>						</code></p><p><code>1740</code><code>			&lt;div id="to-top"&gt;&lt;a href="#wrapper"&gt;To Top&lt;/a&gt;&lt;/div&gt;</code></p><p><code>1741</code><code>			</code></p><p><code>1742</code><code>			&lt;div style="clear:both;"&gt;&lt;/div&gt;</code></p><p><code>1743</code><code>		&lt;/div&gt;</code></p><p><code>1744</code><code>	&lt;/div&gt;</code></p><p><code>1745</code><code>&lt;/div&gt;  </code></p><p><code>1746</code><code>&lt;div&gt;       &lt;div id="for-footer"&gt;</code></p><p><code>1747</code><code>        &lt;ul class="ct-horz-list"&gt;</code></p><p><code>1748</code><code>            &lt;li style="border-left:0;"&gt;&lt;a    href="/ct2/help/for-patient"&gt;For Patients and Families&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1749</code><code>            &lt;li&gt;&lt;a href="/ct2/help/for-researcher"&gt;For Researchers&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1750</code><code>            &lt;li&gt;&lt;a     href="/ct2/help/for-manager"&gt;For Study Record Managers&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1751</code><code>        &lt;/ul&gt;</code></p><p><code>1752</code><code>    &lt;/div&gt;</code></p><p><code>1753</code><code>	</code></p><p><code>1754</code><code>&lt;/div&gt;  </code></p><p><code>1755</code><code>&lt;div id="footer-menu" class="horz-line-above-menu"&gt;</code></p><p><code>1756</code><code>    &lt;ul class="ct-horz-list"&gt;</code></p><p><code>1757</code><code>		&lt;li&gt;&lt;a     href="/ct2/home"&gt;Home&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1758</code><code>		&lt;li&gt;&lt;a     href="/ct2/resources/rss"&gt;RSS Feeds&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1759</code><code>		&lt;li&gt;&lt;a     href="/ct2/sitemap"&gt;Site Map&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1760</code><code>		&lt;li&gt;&lt;a     href="/ct2/about-site/terms-conditions"&gt;Terms and Conditions&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1761</code><code>		&lt;li&gt;&lt;a     href="/ct2/about-site/disclaimer"&gt;Disclaimer&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1762</code><code>		&lt;li&gt;&lt;a     href="https://support.nlm.nih.gov/knowledgebase/category/?id=CAT-01242&amp;amp;category=clinicaltrials.gov&amp;amp;hd_url=http%3A%2F%2Fclassic.clinicaltrials.gov%2Fct2%2Fshow%2FNCT04065399%3Fterm%3DNCT04065399%26draw%3D2%26rank%3D1" onclick="openNewWindow('https://support.nlm.nih.gov/knowledgebase/category/?id=CAT-01242&amp;amp;category=clinicaltrials.gov&amp;amp;hd_url=http%3A%2F%2Fclassic.clinicaltrials.gov%2Fct2%2Fshow%2FNCT04065399%3Fterm%3DNCT04065399%26draw%3D2%26rank%3D1'); return false"&gt;Customer Support&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1763</code><code>	&lt;/ul&gt;</code></p><p><code>1764</code><code>&lt;/div&gt;</code></p><p><code>1765</code><code>          </code></p><p><code>1766</code><code>&lt;/div&gt;  </code></p><p><code>1767</code><code>&lt;div id="fine-print"&gt;</code></p><p><code>1768</code><code>	&lt;ul class="ct-horz-list"&gt;</code></p><p><code>1769</code><code>		&lt;li &gt;&lt;a title="NLM copyright information - opens new window"  href="https://www.nlm.nih.gov/copyright.html" onclick="openNewWindow('https://www.nlm.nih.gov/copyright.html'); return false"</code></p><p><code>1770</code><code>&gt;Copyright&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1771</code><code>		&lt;li &gt;&lt;a title="NLM privacy policy - opens new window"  href="https://www.nlm.nih.gov/privacy.html" onclick="openNewWindow('https://www.nlm.nih.gov/privacy.html'); return false"</code></p><p><code>1772</code><code>&gt;Privacy&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1773</code><code>		&lt;li &gt;&lt;a href="/ct2/accessibility" title="NLM Accessibility"&gt;Accessibility&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1774</code><code>		&lt;li &gt;&lt;a title="NLM viewers and players - opens new window"  href="https://www.nlm.nih.gov/plugins.html" onclick="openNewWindow('https://www.nlm.nih.gov/plugins.html'); return false"</code></p><p><code>1775</code><code>&gt;Viewers and Players&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1776</code><code>		&lt;li &gt;&lt;a title="NIH Freedom of Information Act office - opens new window"  href="https://www.nih.gov/icd/od/foia/index.htm" onclick="openNewWindow('https://www.nih.gov/icd/od/foia/index.htm'); return false"</code></p><p><code>1777</code><code>&gt;Freedom of Information Act&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1778</code><code>		&lt;li &gt;&lt;a title="USA.gov - opens new window"  href="https://www.usa.gov/" onclick="openNewWindow('https://www.usa.gov/'); return false"</code></p><p><code>1779</code><code>&gt;USA.gov&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1780</code><code>		&lt;!--li &gt;&lt;a id="vdp" title="HHS Vulnerability Disclosure - opens new window"  href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" onclick="openNewWindow('https://www.hhs.gov/vulnerability-disclosure-policy/index.html'); return false"</code></p><p><code>1781</code><code>&gt;HHS Vulnerability Disclosure&lt;/a&gt;&lt;/li--&gt;</code></p><p><code>1782</code><code>		&lt;li&gt;</code></p><p><code>1783</code><code>			&lt;a id="vdp" </code></p><p><code>1784</code><code>				href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" </code></p><p><code>1785</code><code>				title="HHS Vulnerability Disclosure" </code></p><p><code>1786</code><code>				target="_blank"&gt;</code></p><p><code>1787</code><code>				HHS Vulnerability Disclosure</code></p><p><code>1788</code><code>			&lt;/a&gt;</code></p><p><code>1789</code><code>		&lt;/li&gt;</code></p><p><code>1790</code><code>	&lt;/ul&gt;</code></p><p><code>1791</code><code>    &lt;ul class="ct-horz-list"&gt;</code></p><p><code>1792</code><code>       &lt;li&gt;&lt;a title="U.S. National Library of Medicine - opens new window"  href="https://www.nlm.nih.gov/" onclick="openNewWindow('https://www.nlm.nih.gov/'); return false"</code></p><p><code>1793</code><code>&gt;U.S. National Library of Medicine&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1794</code><code>       &lt;li&gt;&lt;a title="U.S. National Institutes of Health - opens new window"  href="https://www.nih.gov/" onclick="openNewWindow('https://www.nih.gov/'); return false"</code></p><p><code>1795</code><code>&gt;U.S. National Institutes of Health&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1796</code><code>       &lt;li&gt;&lt;a title="U.S. Department of Health and Human Services - opens new window"  href="https://www.hhs.gov/" onclick="openNewWindow('https://www.hhs.gov/'); return false"</code></p><p><code>1797</code><code>&gt;</code></p><p><code>1798</code><code>            U.S. Department of Health and Human Services&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1799</code><code>    &lt;/ul&gt;</code></p><p><code>1800</code><code>&lt;/div&gt;</code></p><p><code>1801</code><code>          </code></p><p><code>1802</code><code>&lt;script type="text/javascript"&gt;__ncbi_sg_gaMode="clinicaltrials"&lt;/script&gt;</code></p><p><code>1803</code><code>&lt;script type="text/javascript" src="/ct2/html/js/pinger.js?v=2"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>1804</code><code>&lt;script type="text/javascript" src="/ct2/html/js/main-glossary.js?v=48"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>1805</code><code>&lt;script type="text/javascript"&gt;</code></p><p><code>1806</code><code>//OnSubmit routine - copy over some useful data and submit</code></p><p><code>1807</code><code>function sendSearchPing() {</code></p><p><code>1808</code><code>// Get pinger values</code></p><p><code>1809</code><code>var cVals = ncbi.sg.getInstance()._cachedVals;</code></p><p><code>1810</code><code>var app = cVals['ncbi_app'];</code></p><p><code>1811</code><code>var db = cVals['ncbi_db'];</code></p><p><code>1812</code><code>var pdid = cVals['ncbi_pdid'];</code></p><p><code>1813</code><code>var pcid = cVals['ncbi_pcid'];</code></p><p><code>1814</code><code>// Populate search details</code></p><p><code>1815</code><code>var searchDetails = {};</code></p><p><code>1816</code><code>searchDetails['jsevent'] = 'search';</code></p><p><code>1817</code><code>searchDetails['searchtext'] = jQuery('#header-search-query').val();</code></p><p><code>1818</code><code>if (app!=null) searchDetails['ncbi_app'] = app.value;</code></p><p><code>1819</code><code>if (db!=null) searchDetails['ncbi_db'] = db.value;</code></p><p><code>1820</code><code>if (pdid!=null) searchDetails['ncbi_pdid'] = pdid.value;</code></p><p><code>1821</code><code>if (pcid!=null) searchDetails['ncbi_pcid'] = pcid.value;</code></p><p><code>1822</code><code>// Send ping msg</code></p><p><code>1823</code><code>ncbi.sg.ping(searchDetails);</code></p><p><code>1824</code><code>};</code></p><p><code>1825</code><code>&lt;/script&gt;</code></p><p><code>1826</code><code>          </code></p><p><code>1827</code><code>          </code></p><p><code>1828</code><code>&lt;/body&gt;</code></p><p><code>1829</code><code>&lt;/html&gt;</code></p><div></div></main><iframe hidden="hidden" title="Hidden frame for spell checking" src="about:blank" id="iframeSpelling"></iframe></body></html>